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Chapter 1 
General Introduction 
1.1 Fluorescent Protein* 
     Fluorescent proteins (FPs) widely pervade to visualize the dynamics of biological 
phenomenon and act as fluorescent sensors, such as Ca2+, pH, halide, and ATP 
concentration sensors 1-7. Therefore, FPs are indispensable tools for various fields such 
as biochemistry, biophysics and cell biology. Since the Aequorea victoria green 
fluorescent protein (GFP) gene has been cloned 8 and been expressed in other species 
such as Escherichia coli 9, various improved GFPs have been engineered for utilizing as 
bio-imaging tools, like the expansion of the FP color palette and discoveries of GFP-like 
proteins from cnidarian and coral reefs. Enhanced GFP (EGFP), which could offer 
stronger brightness than wild-type GFP, was engineered as useful optical markers 10-12, 
These discoveries and improvements have made FPs more powerful as a good 
visualization tools of molecular-dynamic behavior in biological fields. Moreover, the 
recent discovery of ligand-induced fluorescent proteins (LIFPs), which acquires the 
fluorescent properties by binding exogenous fluorophore, promotes the applications of 
FPs. 
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     The maturation of GFP-like fluorophores is very complicated. The specific 
tri-peptide (X-Tyr-Gly, X means any amino acid) in GFP or GFP-like protein (e.g. 
DsRed) forms fluorophore via three steps of chemical reaction, cyclization, dehydration 
and oxidation (Figure 1.1). When the environment around fluorophore changes via 
intentional alteration such as a site-directed mutagenesis or X in tri-peptide is specific 
amino acid (e.g. X in DsRed is Gln), the positional change of oxidation in tri-peptide 
occurs and induces a subsequent change of the length of conjugated system, and the 
resulting color variations of FPs. However, GFP-like proteins have two weak points. 
First, the maturation of fluorophore was too long, from several tens of hours to several 
days. Second, the fluorophore formation requires oxygen. 
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Figure 1.1. The fluorophore formation of Aqueoria Victoria GFP, the yellow 
mutant GFP (YFP), and red fluorescent protein like DeRed. This figure was based 
on A. Miyawaki, Syujun-sya, 2010 13. The cartoon image of EGFP was created using 
PyMol (DeLano Scientific) from PDB files 2Y0G.
Not only the fluorescence intensity (FI) but also the chromophore maturation is 
important for several biological applications 14, because rapidly maturing fluorescent 
proteins provide efficient fluorescence imaging, and therefore detail maturation rate of 
GFP and its mutants are reported 15. Thus, applications of fluorescent protein as a useful 
probe are required for developments of bio-imaging technology. Recent developments 
of LIFPs have provided further options for researchers using FPs. LIFPs overcome the 
weak points of GFP-like proteins. For example, near-infrared LIFPs, such as IFP1.4, 
which utilize covalently bound biliverdin-related molecule 16, 17 surpassed the longer 
wavelength emission barrier of GFP-like fluorophores, leading to deep tissue/body 
live-cell imaging. Some LIPFs, like iLOV, utilize a non-covalently bound flavin-related 
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molecule 18, 19 and exhibit green fluorescence. FPs have features of instantaneous and 
oxygen-independent fluorophore formation, which the GFP family proteins do not have. 
Figure 1.2 shows the structure of biliverdin-binding fluorescent protein, the precursor of 
IFP1.4 (A) and flavin mononucleotide-binding fluorescent protein, iLOV (B). From 
such features, LIFPs have a potential of novel fluorescent tools instead of GFP family 
proteins and attract in various fields. 
Figure 1.2.  The protein structures of LIFPs. (A) The structure of DrCBD, which is 
the precursor of IFP1.4. (B) The structure of iLOV. Images were created using PyMol 
(DeLano Scientific) from PDB files 1ZTU and 4EET for (A, B), respectively. 
_______________________
* This section is reproduced with permission from Yoh Shitashima, Togo Shimozawa, 
Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two distinct fluorescence states of 
the ligand-induced green fluorescent protein UnaG, Biophysical Journal, 113, 
2805-2814 (2017) 20, Elsevier, copyright 2017. Consent from all authors has been 
secured. 
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1.2 Fatty Acid Binding Protein 
     In this thesis, I focus on UnaG, which was recently discovered green LIFP in eel 
muscles. Before I describe UnaG, I explain the general introduction of fatty acid 
binding protein (FABPs) because UnaG is a member of the FABPs. One of the most 
important functional proteins, FABPs, which are classified various FABP types, like 
heart-type FABP (H-FABP), brain-type FABP (B-FABP) and epidermal-type FABP 
(E-FABP), behave as intracellular carriers for incorporating polyunsaturated fatty acids 
(PUFAs) into cells 21-24. Moreover, FABPs have attracted interest as biomarkers because 
they also play physiological roles. For example, (i) H-FABP, which manages 
intracellular transport of free fatty acids in heart, can be an effective prognostic marker 
for heart failure and/or cardiovascular disease 25, and (ii) B-FABP has a potential role as 
biomarker for glioblastoma and/or dementia 26, 27: because PUFAs are closely related 
with these diseases. Herein, FABPs play important roles to regulate intracellular 
behaviors of fatty acids (FAs) through the interaction between FABPs themselves and 
their ligands, PUFAs (dissociation constant, Kd = 10-7~10-6 M) 28. Hence, intentional 
change of ligand molecular interaction (e.g. binding affinity) would lead to regulating 
FAs’ behaviors. UnaG belongs to FABP family with the highest homology to human 
B-FABP 29. 
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1.3 UnaG** 
     UnaG is a novel green LIFP discovered in eel muscles, is a first reported 
fluorescent protein derived from vertebrates, which is a superfamily of 
fatty-acid-binding protein (FABP) 29. The apo state of UnaG (apoUnaG) high-specificity 
and -affinity binds bilirubin (BR) inside the b-barrel and forms the UnaG-BR complex 
(holoUnaG) (Figure 1.3). Due to the high-affinity of BR binding (Kd = 98 pM) 29 
compared to other FABP holoprotein complexes, almost all UnaG in mammalian cell 
form holo state because of the abundance of BR in vertebrates. BR contains two 
dipyrrinone moieties (endo-vinyl and exo-vinyl dipyrinone), and both moieties absorb 
visible light from 400 nm to 500 nm, however, nobody knows which moieties 
contribute to exhibit fluorescence. Each dipyrrinone moiety has propionate and it forms 
many hydrogen bonds with UnaG. For instance, Arg132/Tyr134 residues anchor the 
endo-vinyl dipyrrinone propionate carboxylate, and Ser80/Asp81 residues attach to the 
propionate carboxylate from exo-vinyl dipyrrinone via a water molecule 29. Hydrogen 
bonds in the former are seen in other FABPs, whereas those in the later are a particular 
feature in holoUnaG. This fact suggests that the anchored propionate carboxylate via 
Ser80/Asp81 residues bears the high affinity of BR binding 29.  
     The fluorescence spectrum and brightness of UnaG bound to BR (holoUnaG) are 
similar to those of EGFP 29. The quantum efficiency (QE) of holoUnaG is ~50%, which 
is equivalent to that of EGFP, one of the brightest GFP mutants, although free BR in 
aqueous solution is almost dark, indicating that holoUnaG is bright enough to be 
detected in living cells. Additionally, the molecular weight of UnaG is 16.5 kDa, which 
is smaller than that of EGFP (27 kDa), indicating that UnaG can be useful tools for 
various fields. By utilizing the binding specificity to BR and the ligand-induced 
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fluorescence, quick measurements of indirect BR concentrations in blood have been 
reported as an application of UnaG 30. Moreover, since the discovery of UnaG, it has 
been utilized for a fluorescent BR sensor 31 or a reversible fluorogenic protein-protein 
interaction reporter 32 in mammalian cells. Furthermore, it has also been utilized for a 
fluorescent hypoxia sensor 33 because UnaG can produces oxygen-independent 
fluorescence.  
Figure 1.3.  The structures of UnaG-Bilirubin complex. Image was created using 
PyMol (DeLano Scientific) from PDB files 4I3B. 
________________________
** This section is reproduced with permission from Yoh Shitashima, Togo Shimozawa, 
Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two distinct fluorescence states of 
the ligand-induced green fluorescent protein UnaG, Biophysical Journal, 113, 
2805-2814 (2017) 20, Elsevier, copyright 2017. This section is also reproduced with 
permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and Atsushi Miyawaki, 
A dual-ligand-modulable fluorescent protein based on UnaG and calmodulin, 
Biochemical and Biophysical Research Communications, 496, 872-879 (2018) 34, 
Elsevier, copyright 2018. Consent from all authors has been secured. 
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1.4 Calmodulin 
Calmodulin (CaM) is known as one of the most famous Ca2+ binding proteins and 
plays numerous physiological roles such as metabolism, apoptosis, muscle contraction, 
and nerve growth. CaM itself changes its conformational structure by binding to Ca2+ 
(Figure 1.4.), further Ca2+-CaM complex drastically change its conformation by binding 
myosin light chain kinase fragment (M13), and this conformationally sensitive feature 
enables CaM to play various important cell functions. From the feature that CaM 
interacts with Ca2+ ion and resulting its conformational change, CaM has been utilized 
for genetically encoded fluorescent Ca2+ indicator3. Recently, various single fluorescent 
protein based indicators have been reported, indicating that CaM is still a useful 
conformational change receptor in protein engineering field. To genetically combine 
UnaG with CaM, I attempt to develop a novel application of UnaG. 
Figure 1.4.  The crystal structure of CaM without Ca2+ (blue) and with Ca2+ 
(yellow). Ca2+ molecules are shown as red spheres. The alignment of both CaMs was 
performed using Pymol (DeLano Scientific) from PDB files 1CFD and 1CLL, 
respectively. NCa2+(-), and CCa2+(-), NCa2+(+), and CCa2+(+) indicated the N or C termini of 
CaM with or without Ca2+, respectively.  
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1.5 Scope of this Thesis 
     In sections 1.3, I describe the feature and utility of UnaG. These previous reports 
imply that UnaG has a potential to be a compact fluorescent probe, which can be 
available in life science field. Despite the great potential of UnaG as a fluorescent probe, 
limited information of UnaG has hindered its application as a fluorescent probe. For 
example, the association/dissociation rate constants between UnaG and BR, which 
govern the fluorescence stability of protein, and the dispersion of UnaG in aqueous 
solution, which influences the functions of labeled proteins, are unknown. As an 
example of the former, if the dissociation rate is not negligible, frequent exchange of the 
ligand could prevent photo-bleaching 35, 36 and realize bright and stable fluorescent 
imaging even under conditions of high-intensity excitation light 37. As an example of the 
latter, multimeric fluorescent proteins such as DsRed discovered in Discosoma sp. are 
difficult to use for bio-imaging because they may aggregate themselves through the 
interaction between fluorescent proteins 38; therefore, monomeric DsRed were 
developed 39. Moreover, although some previous reports have described the application 
of UnaG as BR sensors 30, 31, 33, the high affinity of UnaG itself and BR restrict these 
sensors to irreversible and one-time sensors. Additionally, the high affinity of ligand has 
hindered its utilization as a quantitative BR sensor in vivo because almost all UnaG in 
mammalian cell would form holo state and would exhibit the saturated fluorescence 
even if the concentration of BR is very low. 
     In this thesis, I have two purposes. First, I determined the important molecular 
properties of UnaG for utilizing this protein in life science fields. While analyzing the 
important molecular properties of UnaG such as the association and dissociation rates of 
ligand and the dispersibility of UnaG, I discovered two distinct fluorescence states in 
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holoUnaG. Two distinct fluorescence states and the reversible transition between two 
states is unique feature compared to other FPs. Second, I generated the novel 
UnaG/calmodulin chimeric protein which changes its binding affinity for bilirubin by 
calcium ion. The dual-ligand-controllable fluorescent protein that changes the affinity of 
BR binding depending on the Ca2+ concentration was generated by genetically insertion 
of calmodulin into UnaG. 
     This doctoral thesis contains four chapters. In chapter 1, I describe a general 
introduction of fluorescent protein, especially UnaG, and explain the purpose of this 
thesis. In chapter 2, the fundamental study on UnaG was described. I determined the 
dispersibility of UnaG, the association and dissociation rates of ligand, and two distinct 
fluorescence states in holoUnaG, and suggested a novel schema of the UnaG and BR 
complex system. In chapter 3, the application of UnaG was described. The calmodulin 
insertion around the BR binding pocket of UnaG provided a novel protein that regulates 
the affinity of BR binding by using Ca2+ ion. In chapter 4, I present a summary and 
future prospect of this thesis. 
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Chapter 2 
Two Fluorescence states of UnaG 
2.1 Introduction 
     As described in Chapter 1, important molecular properties of UnaG for their use 
as FPs remain unknown although UnaG has a great potential as a fluorescent probe. 
These include the association/dissociation rate constants and their dispersion in aqueous 
solution. The purpose in this chapter is to investigate the physicochemical properties of 
UnaG. In 2013, UnaG was reported by Miyawaki group at RIKEN, and it has been 
utilized as fluorescent bilirubin determination method in serum. I thought that I would 
like to investigate the physicochemical properties of UnaG, and open the possibility for 
the UnaG applications. I determined the several fundamental features of UnaG such as 
the dispersibility, various rate constants, and fluorescent property from analytical 
ultracentrifugation analysis, spectroscopic analysis, and fluorescent intensity 
distribution analysis (FIDA) (Figure 2.1). The most remarkable achievement in this 
chapter is discovering the distinctive fluorescence intensity transition after addition of 
BR to apoUnaG solution while measuring the association/dissociation rates of UnaG 
and BR. I identified the unique fluorescent property of UnaG by the time-dependent 
green fluorescence of holoUnaG. Interestingly, after addition of BR to apoUnaG 
solution, the solution immediately showed strong fluorescence, and the intensity 
gradually increased to a plateau. Although distinctive photo activation fluorescent 
proteins were reported 1, 2, the fluorescent protein that gradually increased its FI after 
showing strong fluorescence has not been reported. I believed that clarifying the 
mechanism of this unique phenomenon was important for utilizing UnaG as a 
fluorescence probe 3. By using these results, I suggested a novel schema of the UnaG 
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and BR complex system, and determined the various rate constants in the schema. 
Moreover, from analytical ultracentrifugation analysis, I also demonstrated that both 
apoUnaG and holoUnaG exist as monomers in aqueous solution even under conditions 
of 300 mM NaCl. 
This part is reproduced with permission from Yoh Shitashima, Togo Shimozawa, 
Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two distinct fluorescence states of 
the ligand-induced green fluorescent protein UnaG, Biophysical Journal, 113, 2805-14 
(2017) 4, Elsevier, copyright 2017. Consent from all authors has been secured. 
Figure 2.1.  The approach for determination the fundamental study on UnaG. 
Some analyzing methods were used for determining the molecular properties of UnaG 
and finally a novel schema of the UnaG and BR complex system was suggested. The 
cartoon image of UnaG was created using PyMol (DeLano Scientific) from PDB files 
4I3B 5.
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2.2 Experimental Section 
2.2.1 Chemicals 
     BR, dimethylsulfoxide (DMSO), and ampicillin sodium were purchased from 
Wako Pure Chemicals Industries, Ltd. (Osaka, Japan). 
Isopropyl-b-D-thiogalactopyranoside (IPTG) was purchased from Takara Bio Inc. 
(Shiga, Japan). Imidazole was purchased from Tokyo Chemical Industry Co., Ltd. 
(Tokyo, Japan). BR was dissolved in DMSO (1 mM) and stored at −20°C until use. 
 
2.2.2 Preparation of Protein 
     The UnaG gene was provided by Kumagai A. and A. Miyawaki at RIKEN 
(Japan). The UnaG in the pGEX-2T vector was digested via BamHI and EcoRI 
restriction site, and was cloned into the pColdI (Takara Bio Inc., Shiga, Japan) vector. 
The plasmid encoding 6x His-tagged apoUnaG protein (pColdI-UnaG) was introduced 
into E. coli. BL21 cells (Takara Bio Inc.). This transformed E. coli. cell was cultivated 
in LB medium (1% Bacto trypton, 0.5% Bacto yeast extract, 1% NaCl, ph7.0) 
supplemented with ampicillin (100 µg/mL) at 37oC. After cultivation for 3 h, IPTG (0.5 
µM) was added to the medium, and cultivation was continued for an additional 18 h at 
16oC.  Cells were harvested by centrifugation, washed once with potassium phosphate 
buffer (20 mM, pH7.5, K-Pi buffer). Packed by centrifugation, cells were stored at 
−80°C until use. Packed cell were thawed and homogenized by sonication in K-Pi 
buffer for protein purification. The 6x His-tagged apoUnaG was purified from the 
soluble fractions of E.coli. by using HisTrap HP 1mL column (GE Healthcare UK, Ltd., 
Buckinghamshire, U.K.).  The column bound to 6x His-tagged apoUnaG was washed 
with 10 mL wash buffer (pH 7.5) containing K-Pi (20 mM), NaCl (500 mM), and 
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imidazole (20 mM) before elution. 6x His-tagged apoUnaG was eluted with 2.5 mL 
elution buffer (pH 7.5) containing K-Pi (20 mM), NaCl (500 mM), and imidazole (500 
mM), and desalted with a PD-10 column (GE Healthcare UK, Ltd.) equilibrated with 
K-Pi buffer containing Sodium azide (0.02%, vol/vol). The purified protein solution 
stored at 4oC until use. Although the purified 6xHis-UnaG without digestion of the 
6xHis-tag was used, I refer to 6xHis-UnaG as UnaG for simplification of the description 
in this study. 
     The plasmid for expression of UnaG N57A (Arg57 residue was replaced with 
Ala) 5, which showed faint fluorescence, was constructed by using the KOD -Plus- 
Mutagenesis kit (TOYOBO Co., Ltd., Osaka, Japan) according to the instruction 
manual. Mutations were introduced into the UnaG gene in pColdI, and correct 
generation of desired mutations was confirmed by DNA sequencing. 
 
2.2.3 Analytical Ultracentrifugation 
     Sedimentation velocity experiments (AUC-SV) and sedimentation equilibrium 
experiments (AUC-SE) 6, 7 were performed on a Beckman Optima XL-I analytical 
ultracentrifuge at 20oC. There experiments were performed to examine the 
sedimentation coefficient distribution (c(s)) and the molecular weight (MW) of UnaG, 
respectively. The density of buffer and partial specific volume (Vp) of 6 His-tagged 
UnaG were calculated using the SEDNTERP software (http://sednterp.unh.edu/), and 
were set as 1.002 g/ml and 0.74 cm3/g, respectively. On AUC-SV, 400 µl of UnaG (15 
µM, 0.8 absorbance unit (AU) at 280 nm) with BR (7.5 µM) in K-Pi buffer were loaded 
into two channel cells. Absorbance profiles, as a function of radius, were measured at 
280 nm and 500 nm. The data were collected 50 times every 6 minutes at 55K rpm, and 
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analyzed by continuous c(s) distribution model using the SEDFIT software (Peter Shuck, 
NIH; http://www.analyticalultracentrifugation.com/). The c(s) ranging from 0.5 to 14.5 
S were used for examination in wide-range, and 0.2–3 S were used for validation of 
peak shape with a resolution of 200 in both ranges. On s AUC-SE, 100 µl of UnaG at 
9.4 µM, 5.6 µM, and 3.8 µM (0.5, 0.3, and 0.2 absorbance unit, respectively) for 
apoUnaG and 1:1 mixture of UnaG and BR at same concentrations for holoUnaG were 
loaded into six channel cells. The data were analyzed globally at 25K rpm by nonlinear 
least-squares analysis using the ORIGIN software package supplied by Beckman. 
 
2.2.4 Spectroscopic Studies 
     Spectroscopic analysis for excitation and fluorescence spectra and FI time-course 
of holoUnaG were performed using a RF-5300PC spectrometer (Shimadzu Corporation, 
Kyoto, Japan). In all experiment, the excitation wavelength and emission wavelength 
were set at 490 nm and 525 nm, respectively, and both bandwidths were set at 5 nm. 
Circular Dichroism (CD) and absorption spectra were recorded using a J-820 
Spectropolarimeter (JASCO Corporation, Tokyo, Japan). 2 ml of samples containing 
apoUnaG, BR, DMSO (at most 0.2%, vol/vol), and K-Pi buffer were loaded into the 
quartz cuvette having a path length of 1 cm. All data were collected at room 
temperature.  
 
2.2.5 Fluorescence intensity distribution analysis (FIDA) 
     Fluorescence intensity distribution analysis (FIDA) 8, 9 was performed using an 
MF20 apparatus (Olympus Corporation, Tokyo, Japan) with a confocal microscope and 
laser. I used the adjustment Dye Kit 488 nm (MF-D488PX-2) as a control measurement. 
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I measured 50 µl of sample contained apoUnaG (100 nM), BR (10 nM), DMSO (1%, 
vol/vol) in K-Pi buffer (20 mM, pH7.5), and control sample (adjustment Dye Kit 488 
nm, MF-D488PX-2, Olympus Corporation) in glass-bottom 384-well dishes. The 
sample solution was excited by the 100 µW of 488 nm Ar-laser with beam scanner at 
3,600 rpm, and data was measured automatically at a dwell time of 40 µs at each 
monitoring (a total measuring time was 10 s per sample). The data was analyzed 
automatically using software installed in MF20 system. All data were collected at room 
temperature. 
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2.3 Results 
2.3.1 FI Increase in two phases after mixing of UnaG and BR 
     I first attempted to measure the association rate of UnaG and BR by analyzing the 
kinetics of the FI time-course spectrophotometrically after mixing UnaG and BR. 
However, in the process of the evaluation, I found the unique fluorescent property of 
holoUnaG. The FI time-course did not agree with the conventional model assuming a 
simple fluorescent complex formation by binding BR. To confirm the fluorescence 
intensity (FI) transition after adding BR to apoUnaG, I examined the FI time courses 
after adding BR to various concentrations of apoUnaG solution (Figure 2.2A). The 
time-dependent green fluorescence of apoUnaG upon addition of BR indicated that the 
brightness of holoUnaG exhibited two phases; an immediate rapid phase followed by a 
slow phase. The rapid phase would be due to the BR engagement within apoUnaG, 
because (i) the complex formation is the primary event after mixing of UnaG and BR, 
and (ii) the amplitudes of each rapid phase (FI0) increased in proportion to the 
holoUnaG concentration unambiguously, which is equivalent to the amount of 
generated holoUnaG (Figure 2.2B). In addition, the association of apoUnaG and BR 
would be to proceed rapidly because of the high affinity of UnaG and BR (Kd = 98 pM) 
5. On the other hand, the FI time course in slow phase, normalized by each FI0, seemed 
to show the same exponential curve (Figure 2.2C). The fitting analysis of each curve 
was achieved by using the following Equation (2.1) as fitting function: 
FInor (t) = A 1− e−kt( )+1  ･･･Equation (2.1) 
where FInor (t), A and k were the FI at time t, amplitude, and the rate constant, 
respectively. The result in five apoUnaG concentrations suggested the same rate 
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constant and amplitude (k = 4.34 × 10−3 ± 0.18 s−1 and A = 0.78 ± 0.02; Figure 2.2D). 
The simple exponential kinetics of the slow phase, without dependence on the 
concentrations of holoUnaG and free BR, indicated that the FI transition in slow phase 
was not caused by protein-protein association such as holoUnaG itself, and holoUnaG 
and apoUnaG. 
     Furthermore, I examined the sequential BR adding experiments in 1 µM 
apoUnaG solution to ascertain whether the abundance of apoUnaG induced this reaction. 
I added BR four times every 5 minutes to apoUnaG liquid solution, and BR 
concentrations were adjusted to 0 µM, 0.25 µM, 0.5 µM, 0.75 µM and 1 µM, 
respectively (Figure 2.3A). The FI0 after first BR addition was as same as the FI0 after 
fourth BR addition (Figure 2.3B), supporting that FI transition in second phase is not 
caused by the interaction between apoUnaG and holoUnaG. 
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Figure 2.2. Two distinct rates in the FI time-courses upon the mixing of UnaG and 
BR. (A) The FI time-courses after mixing UnaG and BR. BR was added to apoUnaG 
solution (BR:UnaG = 1:1) at various concentrations (in ascending order: 0.25, 0.5, 1.0, 
1.5, 2.0 µM in final concentration) at 0 sec. (B) The plot of the FI amplitudes increases 
in the rapid phase (FI0) vs. the UnaG concentrations in the solution.  (C) Normalized 
FI time-courses in the slow phase displayed in (A) (black dots) with fitting curves 
achieved by using Equation (2.1) (gray line). The time-courses were normalized by 
respective FI0 and were presented with each 0.5 increment on the vertical axis for 
visibility. (D) The plot of the time constants and the amplitudes of FI enhancement 
obtained from the fitting analysis in (C). The time constants (open circles, left axis) and 
the amplitudes (open squares, right axis) had no dependence on the UnaG 
concentrations and were determined to be k = 4.34 × 10−3 ± 0.18 s−1 and A = 0.78 ± 0.02 
on average. Each curve presents in (A) and (C) is a typical curve selected from four 
independent experiments at each UnaG concentration. Data are averages from four 
independent experiments, and error bars indicate standard deviations in (B) and (D). 
Reprinted with permission from Yoh Shitashima, Togo Shimozawa, Akiko Kumagai, 
Atsushi Miyawaki, and Toru Asahi, Two distinct fluorescence states of the 
ligand-induced green fluorescent protein UnaG, Biophysical Journal, 113, 2805-2814 
(2017) 4, Elsevier, copyright 2017. Consent from all authors has been secured. 
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Figure 2.3. Sequential BR adding experiments in 1 mM purified apoUnaG solution. 
(A) Same amount of BR were added four times every 5 minutes (the arrows show the 
BR adding time), and BR concentrations were adjusted to 0 µM, 0.25 µM, 0.5 µM, 0.75 
µM and 1 µM, respectively. Immediately increased FI phase (fast phase) was 
completely separated from gradually increased FI phase (slow phase). (B) The initial FI 
(FI0) after first, second, third and fourth BR addition. 
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2.3.2 The non-relationship between slow phase and protein dissociation 
     The kinetic analyses in Figure 2.2 did not prove the information of involvement 
of holoUnaG dissociation assemblies in the slow FI increase. Therefore, I subjected 
UnaG to analytical ultracentrifugation in order to investigate this possibility. I first used 
the AUC-SV to examine the sediment coefficient distribution (c(s)) of an equimolar 
mixture of apoUnaG and holoUnaG (7.5 m M each) in the same buffer as for the data 
presented in Figure 2.2. Figure 2.4A shows the absorbance profiles measured at 280 nm, 
where both apoUnaG and holoUnaG were detected, with fitting curves by SEDFIT 
using c(s) as parameters. The c(s) distribution obtained from the absorbance profiles 
showed only one symmetrical peak (Figure 2.4B), and this result indicated that both 
apoUnaG and holoUnaG exhibit same sedimentation coefficients (~1.8 S). I also 
measured at a wavelength of 500 nm to determine the sedimentation coefficient of 
holoUnaG, because holoUnaG has the additional maximum absorption around 500 nm 
due to the absorbance of bound BR whereas apoUnaG has only maximum absorption 
around 280 nm. The sedimentation coefficient of holoUnaG has almost the same c(s) 
(Figure 2.5), supporting the identical sedimentation coefficients of apoUnaG and 
holoUnaG. Additionally, the almost same c(s) was obtained under the conditions of high 
NaCl concentration (300 mM) (Figure 2.6). Together with the sedimentation 
coefficients of ~1.8 S and the primary structure of UnaG (140 amino-acid including 
6xHis-tag and linker), it is suggested that both apoUnaG and holoUnaG exist as 
monomers in K-Pi buffer. These results show that the slow FI increase was also not 
caused by dissociation of holoUnaG assemblies. 
     I also used the AUC-SE to determine the dispersion of monomers by directly 
determining the molecular weights (MWs) of apoUnaG and holoUnaG. The absorbance 
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profiles of apoUnaG (Figure 2.4C) and holoUnaG (Figure 2.4D) in sedimentation 
equilibrium (after centrifugation for 16 h) obtained from the global curve fitting of three 
different data and the residuals of the fittings (bottoms in Figure 2.4C and D) are shown. 
The fitted molecular weight of apoUnaG and holoUnaG were estimated to be 20,928 Da 
and 21,299 Da, respectively. These experimental MWs were similar to the MWs 
calculated from the primary structures of apoUnaG (including 6xHis-tag and linker; 
18,651 Da) and holoUnaG (same as above; 19,236 Da). These results indicated that 
both apoUnaG and holoUnaG were monomers in K-Pi buffer.  
     The kinetic analyses (Figure 2.2) and the monomeric dispersion of both apoUnaG 
and holoUnaG (Figure 2.4) indicated that the slow FI increase was associated with an 
intra-molecular reaction within the already formed holoUnaG molecule. These results 
suggested that holoUnaG exists in two states with different fluorescence intensities, 
which were named holoUnaG1 and holoUnaG2. The holoUnaG1 molecule initially forms 
after binding BR, and then changes to the brighter holoUnaG2 molecule by this 
intra-molecular reaction. 
  
28 
Figure 2.4. Analytical ultracentrifugation of apoUnaG and/or holoUnaG. (A) (Top) 
Sedimentation velocity absorbance profiles of an equimolar mixture of apoUnaG and 
holoUnaG (7.5 µM each) in K-Pi buffer (colored dots, higher color temperature indicate 
later time points) with fitting curves (black lines), using c(s) as parameters by SEDFIT 
software. (Bottom) Residuals of the fittings are shown in the bottom panel. The 
absorbance profiles were obtained at 55K rpm and 20°C, and were collected every 6 
min for 300 min. Scans presented here are every 24 min for clarity. The fitting analysis 
was performed with a grid resolution of 200 for 0.5–15 S. (B) The c(s) as a result of the 
fitting analysis in graph (A). (inset) The detailed c(s) obtained by limiting the range of 
c(s) to 1.0–2.5 S with grid resolution of 200. Both c(s) showed a single peak without a 
shoulder. (C and D) (Tops) Sedimentation equilibrium absorbance profiles for various 
concentrations of apoUnaG (C) and holoUnaG (D) (colored circles, blue: 9.4 µM; 
yellow: 5.6 µM; and red: 3.8 µM), and the fitting curves (black lines) that are analyzed 
globally by a nonlinear least-squares method. (Bottoms) Residuals of the fittings are 
shown in the bottom panel. The absorbance profiles were obtained at 25K rpm and 20°C. 
Reprinted with permission from Yoh Shitashima, Togo Shimozawa, Akiko Kumagai, 
Atsushi Miyawaki, and Toru Asahi, Two distinct fluorescence states of the 
ligand-induced green fluorescent protein UnaG, Biophysical Journal, 113, 2805-2814 
(2017) 4, Elsevier, copyright 2017. Consent from all authors has been secured. 
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Figure 2.5. Sedimentation velocity analysis of apoUnaG and holoUnaG mixture 
measured at 500 nm. (A) Sedimentation velocity absorbance profiles, and (B) the c(s) 
as a result of the fitting analysis in graph (A). HoloUnaG has a sedimentation 
coefficient of ~1.8 S. Reprinted with permission from Yoh Shitashima, Togo 
Shimozawa, Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two distinct 
fluorescence states of the ligand-induced green fluorescent protein UnaG, Biophysical 
Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. Consent from all authors 
has been secured. 
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Figure 2.6. Sedimentation velocity analysis of apoUnaG and holoUnaG mixture in 
the presence of 300 mM NaCl. (A) Sedimentation velocity absorbance profiles, and 
(B) the c(s) as a result of the fitting analysis in graph (A) measured at 280 nm. (C) 
Sedimentation velocity absorbance profiles, and (D) the c(s) as a result of the fitting 
analysis in graph (C) measured at 500 nm. Both c(s) showed a single peak without a 
shoulder. Both apoUnaG and holoUnaG have the same sedimentation coefficients of 
~1.8 S at high salt concentration. Reprinted with permission from Yoh Shitashima, Togo 
Shimozawa, Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two distinct 
fluorescence states of the ligand-induced green fluorescent protein UnaG, Biophysical 
Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. Consent from all authors 
has been secured. 
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2.3.3 The two distinct fluorescence states of holoUnaG 
      In order to confirm the presence of the two states of holoUnaG, I utilized the 
fluorescence-intensity distribution analysis (FIDA) to examine the distribution and 
molecular brightness ratio of holoUnaG1 and holoUnaG2 at the plateau of the slow 
phase. The summarized results of FIDA for Rhodamine-110, the standard solution, and 
holoUnaG solution at steady state were given in Table 2.1. The result from the 
Rhodamine-110 solution was well fitted by single component analysis, while the 
holoUnaG solution showed good agreement with the two-component model showing a 
population ratio of 60:40 and molecular brightness ratio of 1:3.9 for 
holoUnaG1:holoUnaG2. This co-existence of holoUnaG1 and holoUnaG2 at plateau of 
the slow phase demonstrates the presence of the two states of holoUnaG and the 
reversibility of the intra-molecular reaction, and finally reaching equilibrium between 
two states. 
     Figure 2.7 shows the details of the UnaG and BR complex system to provide its 
overall schema more clearly. The apoUnaG binds to BR and forms the holoUnaG1, and 
finally changes to the brighter holoUnaG2 by a reversible intra-molecular reaction (k12, 
k21). The BR dissociation pathways for holoUnaG1 and holoUnaG2 (holoUnaGs) were 
shown in dashed arrows because the results obtained in this study indicated that: (i) at 
least either koff1 or koff2, were not 0, and (ii) the unique values of koff1 and koff2 could not 
be determined (as described below). If I had obtained the transient dynamics of the 
distribution of the two states during the slow phase, I could have suggested the reaction 
model more clearly. Note, however, that FIDA can be performed only at the steady state 
because the calibration requires at least ~5 min. 
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Table 2.1. Results of fluorescence intensity distributions analysis 
Sample q1 (kHz) q2 (kHz) C1 (%) C2 (%) c2 
Rhodamine-110 60.5±0.4 - 100 - 1.0 
holoUnaG 11.5±2.1 44.9±1.3 60.3±1.6 39.7±1.6 1.5 
The results from Rhodamine-110 and holoUnaG were fitted by single and two 
component(s) analysis, respectively. The variables q1 and q2 are the photon count rates 
of the components, i.e., the brightness of respective molecular species. The C1 and C2 
are the distributions of respective molecular species. In all cases, the background photon 
count rate was fixed to 0.74 kHz, as measured with K-Pi buffer. Data were averaged 
from ten independent experiments, and error indicates standard deviations of the mean. 
Reprinted with permission from Yoh Shitashima, Togo Shimozawa, Akiko Kumagai, 
Atsushi Miyawaki, and Toru Asahi, Two distinct fluorescence states of the 
ligand-induced green fluorescent protein UnaG, Biophysical Journal, 113, 2805-2814 
(2017) 4, Elsevier, copyright 2017. Consent from all authors has been secured. 
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Figure 2.7. Proposed schema of the UnaG and BR complex system. The holoUnaG1 
was initially formed by the binding of apoUnaG and BR. Then, by a reversible 
intra-molecular reaction, holoUnaG1 changed to holoUnaG2 and brightness increased by 
a factor of 3.9x. The apoUnaG, holoUnaG1, and holoUnaG2 finally reached a state of 
equilibrium. The BR dissociation pathways for holoUnaG1 and holoUnaG2 are indicated 
by dashed arrows because: (i) at least either koff1 or koff2 was not 0; (ii) the unique values 
of koff1 and koff2 could not be determined (for details, see main text). Reprinted with 
permission from Yoh Shitashima, Togo Shimozawa, Akiko Kumagai, Atsushi Miyawaki, 
and Toru Asahi, Two distinct fluorescence states of the ligand-induced green fluorescent 
protein UnaG, Biophysical Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. 
Consent from all authors has been secured. 
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2.3.4 Spectroscopic studies for investigation of the change in BR 
     To confirm the difference of BR fluorophore between holoUnaG1 and holoUnaG2, 
the excitation, emission, circular dichroism (CD) and absorption spectra of the solution 
at the start and the plateau of the slow phase (at 0 and 10 min from the start of the slow 
phase) was measured (Figure 2.8). In case of the excitation and fluorescence spectra, the 
intensity increased ~1.7-fold (Figure 2.8A, inset) with the same spectral shapes, 
indicating that the intra-molecular reaction enhanced the fluorescent efficiency of BR 
without change of the chemical structure. Similarly, both intensity and spectral shape of 
the CD and absorption spectra did not change (Figure 2.8B, upper, CD; lower, 
absorption), suggesting that the intra-molecular reaction did not affect the chemical 
structure change or the conformational change of BR. This result also suggested that no 
additional BR bound to UnaG during the slow phase. Moreover, no changes in the CD 
spectra around UV range indicated that the intra-molecule reaction did not affect the 
secondary structure of UnaG (Figure 2.9). 
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Figure 2.8. Spectroscopic studies to probe the change in bound BR. (A) The 
excitation and fluorescence spectra of 1 µM holoUnaG (both UnaG and BR, 1 µM) at 0 
and 10 min from the start of the slow phase (black and red lines, respectively). Each 
spectrum was normalized by its own FI maximum. (inset) The spectra normalized by 
the FI maxima at 0 min (B) The CD (top) and absorption (bottom) spectra of 1 µM 
holoUnaG were presented in corresponding colors to (A) (UnaG and BR, 1 µM and 5 
µM; The condition was set for excess BR in solution to prevent BR dissociation for 
measurements over a long time period). Reprinted with permission from Yoh 
Shitashima, Togo Shimozawa, Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two 
distinct fluorescence states of the ligand-induced green fluorescent protein UnaG, 
Biophysical Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. Consent from 
all authors has been secured. 
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Figure 2.9. CD and absorption spectra of holoUnaG in UV region at 0 and 5 min 
from the start of the slow phase (both UnaG and BR, 7.5 µM). Reprinted with 
permission from Yoh Shitashima, Togo Shimozawa, Akiko Kumagai, Atsushi Miyawaki, 
and Toru Asahi, Two distinct fluorescence states of the ligand-induced green fluorescent 
protein UnaG, Biophysical Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. 
Consent from all authors has been secured. 
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2.3.5 Analysis of transition rates between holoUnaG1 and holoUnaG2 
     By analyzing the normalized FI time-course of the slow phase, I estimated the 
individual values of k12 and k21. By solving differential equations for the schema (Figure 
2.7), the function was obtained (Equation (2.2)). The derivation of the function was 
described below. I set the condition as follows; (i) the population of holoUnaG1 was 
100% at t = 0, (ii) apoUnaG did not exist in the solution since the high affinity of UnaG 
and BR.  
FInor (t) = α −1( ) ⋅
k12
k12 + k21
⋅ 1− e− k12+k21( )⋅t( )+1  ･･･Equation (2.2) 
where a indicates the brightness ratio of holoUnaG2 to holoUnaG1, and equals to 3.9, as 
obtained by the FIDA (Table 2.1). The time constant in the function (k12 + k21) 
correspond to the apparent transition rate of the slow phase in Figure 2.2D (k = 4.34 × 
10−3 s−1), and the ratio 1/k12:1/k21 should correspond to the molecular distribution of 
60:40 with the two states at steady state (Table 2.1). The k12 and k21 satisfying the two 
restrictions are determined to be 1.72 × 10−3 s−1 and 2.62 × 10−3 s−1, respectively. 
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The derivation of the Equation (2.2) 
     The differential equations for the concentrations of holoUnaG1 and holoUnaG2 
for the schema in Figure 2.7 were described as 
d
dt holoUnaG1[ ] = kon BR[ ] apoUnaG[ ]− k12 + koff 1( ) holoUnaG1[ ]+ k21 holoUnaG2[ ]
d
dt holoUnaG2[ ] = k12 holoUnaG1[ ]− k21 + koff 2( ) holoUnaG2[ ]
 
     Now I consider the situation of the slow phase of the FI increase. The boundary 
conditions were set to (i) all UnaG molecules were in holoUnaG1 at t=0 ([holoUnaG1]0 
= 1), (ii) the dissociation of BR was negligible due to the high affinity of UnaG and BR 
(koff1, koff2, [BR] and [apoUnaG] equal to zero). By some deformations of the formulas 
and solving the differential equations, I obtain,  
holoUnaG1[ ] =
1
k12 + k21
k21 + k12 ⋅e− k12+k21( )t( )
holoUnaG2[ ] =
1
k12 + k21
k12 + k12 ⋅e− k12+k21( )t( )
 
   The brightness of holoUnaG1 and holoUnaG2 were expressed as 1 and a, 
respectively, the normalized FI time-courses was represented by 
FInor (t) = holoUnaG1[ ]+α holoUnaG2[ ] = α −1( ) ⋅
k12
k12 + k21
⋅ 1− e− k12+k21( )t( )+1  
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2.3.6 The association rate constant of UnaG and BR 
     The association rate (kon) of UnaG and BR was determined by analyzing the 
initial velocity of the FI increase in rapid phase. I set the total concentration of BR 
([BR]0) and UnaG ([apoUnaG]0) within 50 nM in final concentration, and measured the 
FI time-courses upon mixing (Figure 2.10). Herein, the FI time-courses do not exhibit a 
simple exponential curve due to the FI enhancement in the slow phase, as described in 
Figure 2.2. Then, I focused on very initial part of the rapid phase, because the 
production of holoUnaG2 and the resulting FI enhancement were negligible (Figure 
2.10A, inset). For determination of the absolute value of kon, the right axis of the inset 
figure shows the holoUnaG1 concentration. For this conversion, I used the relationship 
that the FI0 for 1 nM holoUnaG1 equals to 5.60, which was measured in same manner as 
Figure 2.2 with the identical spectrophotometer setup in Figure 2.10A. The plot of the 
initial velocities of holoUnaG1 generation (Vinit) vs. [BR]0 was shown in Figure 2.10B. 
Using the result of linear regression of this plot and the relationship of Vinit = 
kon·[apoUnaG]0·[BR]0, the associated rate constant was determined to be kon = 7.05 × 
106 M−1s−1. 
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Figure 2.10. The association rate constant of UnaG and BR. (A) The FI time-courses 
upon addition of various concentrations of BR (5, 10 and 20 nM in final conc.) to 
apoUnaG solutions (50 nM, fixed). The total concentration of BR and UnaG in final 
concentration were denoted by [BR]0 and [apoUnaG]0, respectively. (A, inset) The FI 
time-courses focused on the very initial phase and the fitting lines were shown (in order 
from the bottom, [BR]0 = 5, 10 and 20 nM). The right axis shows the concentration of 
holoUnaG1corresponding to the raw FI value. The method to convert the raw FI value to 
holoUnaG1 concentration is described in main text. (B) The plot of the initial velocities 
of holoUnaG1 generation (Vinit) vs. [BR]0 (open circles) and the linear regression line 
(dashed gray line). The association rate constant (kon) was obtained from the slope of 
this plot (kon = 7.05 × 106 M−1s−1). Reprinted with permission from Yoh Shitashima, 
Togo Shimozawa, Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two distinct 
fluorescence states of the ligand-induced green fluorescent protein UnaG, Biophysical 
Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. Consent from all authors 
has been secured. 
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2.3.7 The dissociation rate constant of UnaG and BR 
     In order to measure the apparent dissociation rate from holoUnaGs (koff), I utilized 
the weak-fluorescent UnaG N57A mutant 5, which brightness was approximately 3% 
compared to wild-type (WT) UnaG, as an adsorbent of the free BR dissociated from 
holoUnaGs. First, I validated that the N57A mutant had a high affinity for BR, 
comparable to that of WT UnaG, from the fact that the FI of an equimolar mixture of 
WT holoUnaG and holo N57A mutant (1 µM each) without free BR at equilibrium state 
decreased by half compared to the FI of 1 µM WT holoUnaG (Figure 2.12). Figure 2.11 
showed that exponential FI decay was induced by the addition of a large excess of 
N57A (~80x molar ratio) to WT holoUnaG solution at 0 min. Because the high 
concentration of N57A quickly depleted, the free BR dissociated from the WT 
holoUnaG in the solution. The time constant observed in the FI decay corresponded to 
the apparent dissociation rate of BR from the WT holoUnaG (koff = 2.17 × 10−4 s−1). The 
affinity calculated from koff/kon was Kd = 31 pM and was in good agreement with the 
reported affinity (Kd = 98 pM)5, supporting the validity of our measurement of the two 
rates. 
     The unique values of koff1 and koff2 could not be determined because it was 
impossible to distinguish between the individual BR dissociations from holoUnaG1 and 
holoUnaG2. However, the relationship koff, koff1 and koff2 was obtained by solving the 
differential equations under the condition that the concentration of free BR is negligible 
(Equation (2.3)). The derivation of the function was described below. 
koff =
−A+ A2 − 4B( )
2  ･･･Equation (2.3) 
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where the A and B mean, 
A = k12 + k21 + koff 1 + koff 2
B = k12 ⋅ koff 1 + k12 ⋅ koff 2 + koff 1 ⋅ koff 2  
     The koff1 and koff2 are 0 or positive values that satisfy Equation (2.3). Figure 2.13 
shows the line expressing the possible set of (koff1, koff2), using the parameters obtained 
in this study (koff = 2.17 × 10−4 s−1, k12 = 1.72×10−3 s−1 and k21 = 2.62 × 10−3 s−1). 
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The derivation of the Equation (2.3) 
     The differential equations for the concentrations of holoUnaG1 and holoUnaG2 
for the schema in Figure 2.7 were already described above. Now I consider the situation 
that large excess amount of N57A mutants were added to the WT holoUnaG solution at 
the equilibrium of holoUnaG1 and holoUnaG2 at t = 0. In this situation, the free BR can 
be ignored because of the quick depletion by N57A mutants. By some algebraic 
manipulation and solving the differential equations, I obtain 
holoUnaG1[ ] =C1e
−A+ A2−4B
2
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
⋅t
holoUnaG2[ ] =C2e
−A+ A2−4B
2
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
⋅t  
where the A and B mean 
A = k12 + k21 + koff 1 + koff 2
B = k12 ⋅ koff 1 + k12 ⋅ koff 2 + koff 1 ⋅ koff 2  
and the C1 and C2 can be determined from the boundary conditions, i.e., the initial 
concentrations of holoUnaG1 and holoUnaG2, as follows 
C1 =
k12
k12 + k21
⋅ UnaG0[ ]
C2 =
k21
k12 + k21
⋅ UnaG0[ ]
 
where the [UnaG0] mean the total concentration of UnaG proteins in the solution. 
     The apparent dissociation rate (koff) correspond to the time constant in the 
formulas above, therefore, I finally obtain 
koff =
−A+ A2 − 4B( )
2  
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Figure 2.11. The dissociation rate constants of UnaG and BR. The FI time-course 
upon addition of 80x excess N57A (weak-fluorescent mutant) apoUnaG to the WT 
holoUnaGs solution at equilibrium state (opened circles) and fitting curve (gray line). 
The FI decay was well-fitted with a single exponential function with the time constant 
of 2.17 × 10−4 s−1. Reprinted with permission from Yoh Shitashima, Togo Shimozawa, 
Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two distinct fluorescence states of 
the ligand-induced green fluorescent protein UnaG, Biophysical Journal, 113, 
2805-2814 (2017) 4, Elsevier, copyright 2017. Consent from all authors has been 
secured. 
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Figure 2.12. A comparison of FI time-courses between an equimolar mixture of WT 
holoUnaG and holo N57A mutant and the FI of 1 µM WT holoUnaG. The curves 
were normalized to the FI of WT UnaG at 10 min. Reprinted with permission from Yoh 
Shitashima, Togo Shimozawa, Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two 
distinct fluorescence states of the ligand-induced green fluorescent protein UnaG, 
Biophysical Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. Consent from 
all authors has been secured. 
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Figure 2.13. An example of relation between koff1 and koff2. The possible values of 
(koff1, koff2) were expressed by points on the solid line, using the Equation (2.3) and the 
koff, k12 and k21 values at the condition of 0 mM NaCl in Table 2.2. Reprinted with 
permission from Yoh Shitashima, Togo Shimozawa, Akiko Kumagai, Atsushi Miyawaki, 
and Toru Asahi, Two distinct fluorescence states of the ligand-induced green fluorescent 
protein UnaG, Biophysical Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. 
Consent from all authors has been secured. 
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2.3.8 Effect of chloride ion concentration on interaction of UnaG and BR 
     The effects of solution conditions on the interaction properties of UnaG and BR 
were assayed by measuring the k, kon and koff at high chloride ion (K-Pi buffer 
containing 150 mM NaCl) in same manner as for the data in Figure 2.2, Figure 2.10 and 
Figure 2.11, and summarized in Table 2.2 to compare with the rates under the condition 
of 0 mM NaCl. I also examined FIDA for determining the distribution and brightness 
ratios of holoUnaG1 and holoUnaG2 at 150 mM NaCl. All rate constants were affected 
by chloride ion, although the distribution and the brightness ratios were not. The kon was 
lowered by a factor of ~0.20 by increasing NaCl to 150 mM, whereas k and koff were 
increased by factors of ~1.54 and 2.36, respectively. 
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Table 2.2. Kinetic rate constants of the UnaG and BR complex system with or 
without NaCl 
Contents NaCl 0 mM NaCl 150 mM 
kon 7.05 × 106 (M-1s-1) 1.42 × 106 (M-1s-1) 
koff 2.17 × 10-4 (s-1) 5.13 × 10-4 (s-1) 
k 4.34 × 10-3 (s-1) 6.69 × 10-3 (s-1) 
k12 1.72 × 10-3 (s-1) 2.66 × 10-3 (s-1) 
k21 2.62 × 10-3 (s-1) 4.03 × 10-3 (s-1) 
The k12 and k21 were calculated from the apparent rate k using Equation (2.2), the 
brightness ratio (1:3.9) and the population ratio (60:40) of holoUnaG1 and holoUnaG2. 
Reprinted with permission from Yoh Shitashima, Togo Shimozawa, Akiko Kumagai, 
Atsushi Miyawaki, and Toru Asahi, Two distinct fluorescence states of the 
ligand-induced green fluorescent protein UnaG, Biophysical Journal, 113, 2805-2814 
(2017) 4, Elsevier, copyright 2017. Consent from all authors has been secured. 
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2.4 Discussion 
2.4.1 Dispersibility of UnaG and other fluorescent proteins 
     The dispersibility of FPs should be investigated to perform live cell fluorescence 
imaging correctly, because in most cases, the oligomer formation disturbs functions of 
labeled proteins, leading to abnormal cell behavior. For example, the DsRed derived 
from coral reefs tend to form strong tetramers, therefore the genetically-engineered 
monomeric versions of DsRed are preferred by current researchers for fluorescence 
imaging 10-12. In this study, I demonstrated that both apoUnaG and holoUnaG are 
monomers even under conditions of high NaCl concentration, at least up to 7.5 µM. I 
also demonstrated that both apoUnaG and holoUnaG exist as monomeric forms in the 
presence of 1% w/v of PEG 6000, at least up to 6.5 µM (Figure 2.14). These facts 
indicated that both apoUnaG and holoUnaG exhibited monomeric dispersion in various 
conditions. However, it is known that the WT GFP forms a weak dimer at Kd = 0.11 
mM 13, and the aggregation of the labeled proteins due to the dimerization of the WT 
GFP could disrupt cellular structures and functions 14. From this perspective, the 
dispersibility of UnaG in higher concentrations should be examined further. 
     The differences between the experimental and theoretical MWs in this study 
(Figure 2.4) arose from an error in the Vp, one of the physical constants of proteins used 
in the fitting analysis. This is because the Vp of UnaG (0.721 cm3/g) was estimated from 
the primary structure by SEDNTERP software, although the Vp values for proteins are 
affected by the conformation of the proteins. In fact, substituting the Vp for 0.708 cm3/g 
can give the theoretical MW of UnaG, which is within the range of Vp values generally. 
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Figure 2.14. Sedimentation velocity analysis of apoUnaG and holoUnaG mixture in 
the presence of 1% w/v of PEG 6000. (A) Sedimentation velocity absorbance profiles, 
and (B) the c(s) as a result of the fitting analysis in graph (A) measured at 280 nm. (C) 
Sedimentation velocity absorbance profiles, and (D) the c(s) as a result of the fitting 
analysis in graph (C) measured at 500 nm. Both c(s) showed a single peak without a 
shoulder. Both apoUnaG and holoUnaG have the same sedimentation coefficients of 
~1.7 S in the presence of 1% w/v of PEG 6000. Reprinted with permission from Yoh 
Shitashima, Togo Shimozawa, Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two 
distinct fluorescence states of the ligand-induced green fluorescent protein UnaG, 
Biophysical Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. Consent from 
all authors has been secured. 
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2.4.2 The possibility of the transition between the two states in holoUnaG 
     At first, I assumed that the slow phase of the FI increase arose from additional BR 
binding to an unknown second ligand site in UnaG. This is because albumin such as 
BSA and HSA, which are well-known BR binding proteins, can both bind two BRs with 
different affinities 15, 16. However, in the case of UnaG, the independence of the slow 
phase kinetics on the concentration of free BR indicated that the slow phase was not 
caused by additional BR binding. In addition, as spectroscopic studies in UnaG, the 
unchanged CD spectra during the slow phase also negated the possibility of a second 
BR binding site in UnaG, because the binding of free BR to UnaG and the resulting 
conformational fixation of BR inevitably caused the change in the CD spectrum 5, 17. 
     I next assumed a translocation or rearrangement of bound BR to another site with 
a change in brightness. I were aware that the liver-type FABP (FABP1), which has a 
high degree of homology and similar tertiary structure to UnaG, has a bound palmitic 
acid that causes translocation from the initial superficial site to a deeper site with a large 
conformational change 18. However, in the case of UnaG, the unchanged CD spectra 
during the slow phase (Figure 2.8) indicated that the BR bound to holoUnaG did not 
alter its conformation, as seen in FABP1. 
     The kinetics of the slow phase (Figure 2.2) and the co-existence of the two states 
at the equilibrium state (Table 2.1) indicated that the slow phase was associated with a 
reversible intra-molecular reaction. It is well-known that some GFP family proteins 
have the protonation/deprotonation states of their fluorophores accompanying the 
change of absorption spectra 19-21. In the case of holoUnaG, however, the unchanged 
shape of the absorption spectra during the slow phase (Figure 2.8) indicated that bound 
BR does not exchange protons, because the protonation/deprotonation of fluorophores 
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would be reflected in the shape of the absorption spectra between holoUnaG1 and 
holoUnaG2. 
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2.4.3 Proposed mechanisms of transition between the two states 
     The results of the spectroscopic analysis suggested that the reversible 
intra-molecular reaction was not associated with the chemical and conformational 
change of BR and UnaG (Figure 2.8). These results implied that the intra-molecular 
reaction was associated with a change in the environmental conditions surrounding BR. 
The effects of chloride ion on the k, kon and koff (Table 2.2) indicated that the 
electrostatic force may play important roles in the transition between holoUnaG1 and 
holoUnaG2 as well as the interaction of UnaG and BR. I also determine the effect of 
iodine ion on the k, kon and koff, and summarized in Table 2.3. Although the iodine ion 
affects the value of k compare to chloride ion (Figure 2.15), the effects of iodide ion 
were the same as chloride ion (Table 2.3). The effects on the kon and koff could be simply 
explained by the charge screening effect, where electrostatic attraction and binding 
affinity between UnaG and BR are reduced by the surrounding ions in a solution, as 
also observed in the interaction of adipocyte-type FABP and associated ligand 22. On the 
other hand, the increase in k at higher chloride ion is highly suggestive of the 
involvement of electrostatics in the reversible intra-molecular reaction, because the 
increase in k indicate the reduction of energy barrier separating holoUnaG1 and 
holoUnaG2, for example, the activation energy of the intra-molecular reaction. 
     Based on the consideration described above, a bi-stable switch in the direction of 
a polar residue proximal to BR is one reasonable explanation of the reversible 
intra-molecular interaction and the resulting FI change. I speculated that a polar residue, 
not associated with BR but another atom in holoUnaG1, could be associated with BR in 
holoUnaG2 through hydrogen bonds or electrostatic interactions due to the bi-stable 
directional change, which is driven by thermal fluctuations over the energy barrier 
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separating the two states. In fact, the alternative direction of a polar residue proximal to 
fluorophore and the resulting alternative interaction network between fluorophore and 
proximal residues were observed in EGFP 23. In general, these changes are reflected in 
the fluorescence QE of fluorophore. These include the changes in electronic state of 
fluorophore, stabilization/destabilization of fluorophore by altering the network of 
hydrogen bonds and other interactions 24, and hydration state of fluorophore 23, 25. 
     Arg57 is a potential candidate residue that may be associated with BR in this 
manner. As shown with the significant weak-fluorescence of N57A holoUnaG 5, the 
fluorescence QE of holoUnaG was sensitive to the relationship between Arg57 and BR. 
Moreover, N57A did not exhibit the slow phase of FI increase after binding BR (Figure 
2.16). These results indicated that Arg57 plays a key role not only in the basal 
fluorescence efficiency of UnaG, but also in the transition between holoUnaG1 and 
holoUnaG2. 
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Table 2.3. Kinetic rate constants of the UnaG and BR complex system with or 
without halide (chloride or iodine ion)  
Contents Non-salt NaCl 150 mM KI 150 mM 
k 4.34 × 10-3 (s-1) 6.69 × 10-3 (s-1) 14.6 × 10-3 (s-1) 
kon 7.05 × 106 (M-1s-1) 1.42 × 106 (M-1s-1) 2.13 × 106 (M-1s-1) 
koff 2.17 × 10-4 (s-1) 5.13 × 10-4 (s-1) 2.76 × 10-4 (s-1) 
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Figure 2.15. Normalized FI time-courses in the slow phase (colored dots) with 
fitting curves achieved by using Equation (2.1) (black line).  
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Figure 2.16. Normalized FI time-courses after mixing WT/N57A UnaG and BR. 
Excess amounts of BR (5 µM in final conc.) were added to 1 µM of WT or N57A 
apoUnaG solution at t = 0. The curves were normalized to the amplitude of rapid phase 
on the FI increase (FI0). Reprinted with permission from Yoh Shitashima, Togo 
Shimozawa, Akiko Kumagai, Atsushi Miyawaki, and Toru Asahi, Two distinct 
fluorescence states of the ligand-induced green fluorescent protein UnaG, Biophysical 
Journal, 113, 2805-2814 (2017) 4, Elsevier, copyright 2017. Consent from all authors 
has been secured. 
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2.5 Conclusion 
     In conclusion, I have demonstrated that holoUnaG exhibits two different 
fluorescence intensities. From FIDA result, I determined that holoUnaG1 was gradually 
converted to holoUnaG2, which acquired 3.9 times higher brightness, and finally both 
holoUnaG1 and holoUnaG2 reached equilibrium state with an average 
holoUnaG1/holoUnaG2 ratio of 60:40. I reasoned that slight conformational changes of 
amino acid residues around ligand-binding site would induce the changes from 
holoUnaG1 to holoUnaG2; especially the N57 is a key residue that triggers these 
changes. I also determined the association and dissociation rate constants between 
UnaG and BR, and provided a novel schema of the UnaG and BR complex system.  
     The findings of this study provide key information for the practical use of UnaG. 
For example, when I quantify the amount of BR in vitro or in vivo from the fluorescence 
signal of holoUnaG, the equilibration time (several minutes) for the two states must be 
taken into account. The quantum efficiency (QE) of holoUnaG has been reported as 
51% 5, although this was measured at equilibrium for the two states. The individual QEs 
of holoUnaG1 and holoUnaG2 correspond to 23% and 92% respectively, according to 
their distribution at equilibrium (60:40) and the molecular brightness ratio (1:3.9) 
determined in this study. I suggest that the QE of holoUnaG2 is the highest value for BR. 
The discovery of a higher QE for holoUnaG2 opens the possibility for the development 
of a brighter UnaG with the construction of a constitutive holoUnaG2 by genetic 
engineering. 
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Chapter 3 
A Ca2+-dependent Bilirubin Releasing Protein Based on UnaG 
3.1 Introduction 
     In Chapter 2, I described important molecular properties of UnaG for their use as 
FPs, such as the association/dissociation rate constants of ligands and their dispersion in 
aqueous solution. This study provides us the information of the practical use of UnaG; 
for example, (i) UnaG do not express self-aggregation under several conditions, at least 
up to 7.5 µM, and (ii) relatively low koff value of ligands would provide the high affinity 
of ligand to UnaG. For next challenge, I attempted to generate novel functional protein 
based on UnaG. I focused on the ligand of UnaG, bilirubin (BR), which has attracted in 
the physiological field for decades. Since it is well known that excess accumulation of 
BR causes several clinical symptoms such as jaundice, BR has been an important 
diagnostic index in clinical medicine 1, 2. On the other hand, BR containing a reactive 
hydrogen atom and conjugated double bonds is known to be a notable antioxidant 
scavenger for reactive oxygen species (ROS) in biological tissues 3, 4, especially in 
biological membranes. Therefore, optimal regulation of BR concentrations in biological 
tissues could steer clinical therapies for aging, as well as avoiding the risk of certain 
diseases that are caused by BR accumulation. However, UnaG hardly releases BR 
because of the very high affinity interaction involving UnaG and BR, especially its low 
koff value. 
     The purpose in chapter 3 is to engineer the binding of UnaG to be sensitive to free 
calcium ion. I attempted to engineer the BR binding of UnaG to be sensitive to free Ca2+. 
The strategy of designing the protein was devised from the single fluorescent 
protein-based indicator (SFPBI) 5. I speculated that the insertion of calmodulin (CaM) 
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near the BR binding pocket of UnaG would result in the production of a novel 
fluorescent protein that releases the fluorophore in a Ca2+-dependent manner. This is 
because that one of the SFPBI, Camgaroo1 6, was generated by insertion of CaM into 
Enhanced yellow fluorescent protein (EYFP) and the generated protein could change its 
fluorescent intensity (FI) by Ca2+. Recently, To et al. developed the “UnaG-based 
protein-protein interaction reporter (uPPI)” by using the protein-fragment 
complementation approach7. They revealed that the site between residues 84 and 85 of 
UnaG was tolerant to protein insertion. In addition, as the site was close to Ser80/Asp81 
residues, Ca2+-dependent conformational change due to CaM insertion was expected to 
affect the anchoring of the propionate carboxylate from exo-vinyl dipyrrinone. 
     Remarkably, one of the UnaG/CaM chimeric proteins constructed in this study, 
termed BReleaCa (indicating BR + releaser + Ca2+), decreased BR affinity and 
accordingly the green fluorescence intensity (FI) markedly with Ca2+. I investigated the 
association/dissociation kinetics between BReleaCa and BR by monitoring fluorescence 
as the readout and provide mechanical insights into the interplay between BR and Ca2+ 
on the dual-ligand-modulable protein. 
     This part is reproduced with permission from Yoh Shitashima, Togo Shimozawa, 
Toru Asahi, and Atsushi Miyawaki, A dual-ligand-modulable fluorescent protein based 
on UnaG and calmodulin, Biochemical and Biophysical Research Communications, 496, 
872-879 (2018) 8, Elsevier, copyright 2018. Consent from all authors has been secured. 
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3.2 Experimental Section 
3.2.1 Chemicals 
     Bilirubin (BR), dimethylsulfoxide (DMSO), and ampicillin sodium were 
purchased from Wako Pure Chemicals Industries, Ltd. (Osaka, Japan). 
Isopropyl-b-D-thiogalactopyranoside (IPTG) was purchased from Carbosynth Ltd. 
(Berkshire, U.K.). HEPES was purchased from Dojindo Lab. (Kumamoto, Japan). 
Ethylene glycol-bis(b-aminoethyl ether)-N,N,N’,N’-tetraacetic acid tetrasodium salt 
(EGTA-Na) was purchased from Sigma-Aldrich Co. LLC (St. Louis, MO, U.S.A.). 
Calcium Calibration Buffer Kit #1 was purchased from Thermo Fisher Scientific 
(Waltham, MA, U.S.A.). BR was dissolved in DMSO at 1 mM or at 25 mM, and stored 
at −20°C until use. 
 
3.2.2 Preparation of Proteins 
     Calmodulin (CaM) and mCherry were acquired from Addgene plasmid 40753, 
and 35687, respectively (Cambridge, MA, U.S.A.). pColdI-UnaG was prepared as 
described in Chapter 2 9. To create BReleaCa, CaM was inserted into UnaG between 
residues 84 and 85 with both ends employing tetrapeptide linkers (GGSG-CaM-GGSG) 
at the 19-bp overlapping sequences by a SLiCE reaction 10, 11, resulting in 
pColdI-BReleaCa. BReleaCa expression and purification were performed as described in 
Chapter 29 with changing K-Pi buffer (20 mM potassium phosphate buffer adjusted to 
pH 7.5) to HEPES buffer (100 mM HEPES buffer containing 150 mM NaCl, adjusted to 
pH 7.5). Although I used the purified 6x His-BReleaCa without digestion of the 6x 
His-tag, I refer to 6x His-UnaG as BReleaCa for simplification of the description in this 
study. 
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3.2.3 Spectroscopic Studies 
     The measurements of excitation and fluorescence spectra and FI time-course of 
BReleaCa were performed using an RF-5300PC spectrophotometer (Shimadzu, Kyoto, 
Japan), and an F-2500 spectrophotometer (Hitachi Ltd., Tokyo, Japan). For the 
measurements of the FI time-course, BR titration experiments, and measuring Kd, the 
excitation and emission wavelength were set at 490 nm and 525 nm, respectively. 
Absorption spectra were recorded using a V-660 spectrophotometer (JASCO 
Corporation, Tokyo, Japan). The formation of BReleaCa binding to BR (BR-BReleaCa) 
was triggered by the addition of a small volume of high concentration BR dissolved in 
DMSO (1 mM or 25 mM) to 2 ml BReleaCa in a 10 mm path quartz cuvette. For 
changing internal Ca2+ concentration, calcium chloride (CaCl2) or EGTA-Na (pH 7.5) 
dissolved in ultra pure water (1 M each) were added. The measurements of dissociation 
rate constants were performed using an RF-5300PC spectrophotometer (Shimadzu, 
Kyoto, Japan). As described previously, the FI of BR-BReleaCa was monitored after the 
addition of a nonfluorescent BR scavenger UnaG(N57A) 8.All data other than those for 
Kd were collected at room temperature. Kd data were collected at 20oC. 
 
3.2.4 Stopped-flow Analysis 
     The measurements of association rate constants were performed using an SX20 
Stopped-Flow Spectrometer (Applied Photophysics, Leatherhead, U.K.). Equal volumes 
of a 2 µM BReleaCa solution and a 2 µM BR solution were rapidly mixed, and thus the 
total concentrations of BReleaCa and BR ([BReleaCa]t and [BR]t, respectively) were 
both 1 µM. Since the fluorescence of BR-BReleaCa is considerably bright, it is possible 
to reproducibly characterize the rapid increase in FI (dFI/dt), which should be 
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proportional to the initial rate of the generation of BR-BReleaCa (d[BR-BReleaCa]/dt). 
In principle, I calculated kon using the relationship: d[BR-BReleaCa]/dt = kon 
×[BReleaCa]t × [BR]t. To convert measured FI into [BR-BReleaCa], I performed some 
stoichiometry calculations. First, I determined the steady state values of [BR-BreleaCa] 
using Kd (Ca2+(-)) and Kd (Ca2+(+)). Then, assuming that the entire process of fluorescence 
development is composed of a rapid and a slow phases as was shown with UnaG 8, I 
calculated the maximum [BR-BReleaCa] values given by the rapid phase. All data were 
collected at a room temperature. 
 
3.2.5 Cell Culture and Transfection 
     To generate BReleaCa-mCherry for expression in HeLa S3 cells, BReleaCa and 
mCherry were assembled by a SLiCE reaction at the C terminus of BReleaCa with a 
nonapeptide linker (GGSGGSGGS). BReleaCa-mCherry was cloned into the pcDNA3 
vector between the EcoRI and XbaI restriction sites using a SLiCE reaction. Cells were 
passaged in low-glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS) and 0.1% penicillin-streptomycin. HeLa S3 cells, 
grown in 35 mm glass-based dishes, were transiently transfected with 
pRK5-HA-BReleaCa-mCherry plasmid (1 mg per dish) using polyethylenimine (PEI, 2 
m l per 1 mg DNA). Transfection was performed when cells were cultured to ~60-70% 
confluence, and cells were imaged around 24 h after transfection. 
 
3.2.6 Fluorescent Microscopy 
     Transfected HeLa S3 cells were imaged in 35 mm glass-based dishes using an 
IX70 inverted microscope (Olympus Corporation, Tokyo, Japan) with a standard 75-W 
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xenon lamp, a 20x air objective lens (UPlanSApo, numerical aperture 0.70), and a 
CoolSNAP HQ2 CCD camera (Photometrics, Tucson, AZ, U.S.A.). Optical filters were 
automated using Lambda 10-2 hardware (Sutter instruments Co., Novato, CA, U.S.A.) 
with the following excitation and emission filters: 485DF15-nm/530DF30-nm for 
BReleaCa imaging, and 550DF30-nm/590DF35-nm for mCherry imaging, 
excitation/emission respectively. A 455DRLP dichroic mirror and 33% neutral density 
filter (N.D.3) was typically used. Before imaging, samples were prepared as follows: (i) 
removal of DMEM, (ii) washing of the cells with phosphate buffered saline (PBS) 
containing 1 mM ethylendiaminetetraacetic acid (EDTA), (iii) adding Hanks’ balanced 
salt solution without calcium and magnesium (HBSS(-)) containing 100 µM EGTA-Na 
and 100 nM BR, (iv) washing extracellular BR out, (v) standing over 15 min at 
atmosphere. For changing intracellular Ca2+ concentration, 1 mM CaCl2 containing 1 
µM ionomycin, or 2 mM EGTA-Na were added. Images were acquired with exposure 
times of 200 ms for BReleaCa and 500 ms for mCherry, respectively. Data were 
collected at room temperature. The whole system was controlled using MetaFluor 
software (Molecular Devices, Sunnyvale, CA, U.S.A.). Images were analyzed using the 
ImageJ software (NIH, Bethesda, MD, U.S.A.). 
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3.3 Results 
3.3.1 Fusion of CaM to UnaG 
      In this study, I attempted to insert CaM into UnaG at the site between residues 
84 and 85 (Figure 3.1). I first designed two chimeric proteins (Figure 3.2, #1, 2) by 
inserting CaM-derived peptides with tetrapeptide linkers (GGSG) into UnaG 12 at the 
site between residues 84 and 85. A previous study showed that the site was tolerant of 
insertion of foreign proteins 7. However, insertion of a 29 amino acid peptide or a 12 
amino acid peptide containing the 3rd calcium binding region of CaM (III) resulted in a 
significant misfolding of UnaG. Then I substituted a whole CaM protein for the insert 
(Figure 3.2, #3) and was able to make UnaG fold well. After expression in E coli, 
protein #3 was affinity-tag purified for reconstitution with BR. The addition of 1 µM 
BR in the presence of 100 µM EGTA-Na elicited an immediate development of green 
fluorescence that reached a plateau in approximately 20 min (Figure 3.3A, BR 1 µM). 
Interestingly, however, a subsequent addition of 200 µM CaCl2 quenched the 
fluorescence rapidly to nearly zero (Figure 3.3A, CaCl2 200 µM). It was speculated that 
the conversion from apo-CaM to holo-CaM induced either the dissociation of BR from 
UnaG or the decrease of the fluorescence quantum yield of UnaG.  
     To discriminate these two possibilities, I next performed absorption 
measurements. It is known that free and UnaG-bound BR molecules absorb light 
maximally at 448 nm (e = 55,000 M-1cm-1) and 498 nm (e = 77,300 M-1cm-1) 13. The 
absorption spectra in the presence and absence of free Ca2+ were characterized 
exclusively by 448- and 494- nm peaks, respectively (Figure 3.3B, C), suggesting that 
the Ca2+-saturated chimeric protein had no bound BR in the ligand cavity. As protein #3 
appeared to release BR in response to Ca2+, I named it “BReleaCa”. Importantly, I was 
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able to restore the BR binding (Figure 3.3A, EGTA 400 µM) for a subsequent BR 
release again (Figure 3.3A, CaCl2 400 µM) by controlling free Ca2+ concentrations, 
confirming the reversible performance of BReleaCa. 
     I also tried using a CaM-M13 hybrid protein as the insert (Figure 3.2, #4). 
Furthermore, as residues 84 and 85 of UnaG are a site that tolerates circular permutation 
where two portions of the polypeptide are flipped around 14, I generated constructs in 
which circularly permuted UnaG (cp85UnaG) was sandwiched by CaM and M13 
(Figure 3.2, #5, 6). However, neither of them folded well enough for BR incorporation.     
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Figure 3.1. Crystallographic structure of holoUnaG. (A) Overall structure of 
UnaG-BR complex. The site between residues 84 and 85 for insertion of foreign 
peptides is indicated. The image was created using PyMol (DeLano Scientific) from 
PDB file 4I3B13. (B) The bound BR in (A). BR is shown as a stick representation with 
atoms colored (carbon, yellow; oxygen, red; nitrogen, blue; hydrogen, gray). Rings A/B 
and rings C/D compose the endo-vinyl dipyrrinone and exo-vinyl dipyrrinone moieties. 
NT, amino terminus. CT, carboxyl terminus. Reprinted with a modification and with 
permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and Atsushi Miyawaki, 
A dual-ligand-modulable fluorescent protein based on UnaG and calmodulin, 
Biochemical and Biophysical Research Communications, 496, 872-879 (2018) 8, 
Elsevier, copyright 2018. Consent from all authors has been secured. 
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Figure 3.2. Schematic domain structures and sequences of UnaG/CaM hybrid 
proteins for expression in E. coli. Amino acid compositions (G, glycine; S, serine) of 
linkers are shown above the structures. His6, hexa-histidine tag. (#1) E-III-F: a 29 amino 
acid peptide containing the 3rd calcium binding region of rat CaM. (#2) III: a 12 amino 
acid peptide containing the 3rd calcium binding region of rat CaM. (#3) Insertion of the 
entire protein of rat CaM. This protein was further characterized as BReleaCa in the 
present study. (#4) Insertion of CaM-M13. (#5) cp85UnaG-GGSSG was generated by 
linking the original N and C termini through a penta-peptide linker (GGSSG), rendering 
residues 85 and 84 new N and C termini, respectively. (#6) cp85UnaG-GGSSGG was 
generated by linking the original N and C termini through a hexa-peptide linker 
(GGSSGG), rendering residues 85 and 84 new N and C termini, respectively. Reprinted 
with a modification and with permission from Yoh Shitashima, Togo Shimozawa, Toru 
Asahi, and Atsushi Miyawaki, A dual-ligand-modulable fluorescent protein based on 
UnaG and calmodulin, Biochemical and Biophysical Research Communications, 496, 
872-879 (2018) 8, Elsevier, copyright 2018. Consent from all authors has been secured. 
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Figure 3.3. BReleaCa: A fluorescent protein that releases BR reversibly in a 
Ca2+-dependent manner. (A) A time course of intensity of fluorescence from a 2 ml 
solution containing 1 µM BReleaCa and initially 100 µM EGTA-Na. Then, a 4 µl 
solution of 100 mM CaCl2, an 8 µl solution of 100 mM EGTA-Na, and an 8 µl solution 
of 100 mM CaCl2 were sequentially added. Final concentrations of the added solutes are 
indicated. (B) Absorption spectra of BReleaCa during the transition process from the 
Ca2+-depleted to Ca2+-saturated forms. (C) Absorption spectra of BReleaCa during the 
transition process from the Ca2+-saturated to Ca2+-depleted forms. (B, C) As was done 
in the experiment of (A), CaCl2 and EGTA-Na (final conc. 200 µM and 400 µM, 
respectively) were sequentially added after reconstitution of BReleaCa with BR. 
Reprinted with permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and 
Atsushi Miyawaki, A dual-ligand-modulable fluorescent protein based on UnaG and 
calmodulin, Biochemical and Biophysical Research Communications, 496, 872-879 
(2018) 8, Elsevier, copyright 2018. Consent from all authors has been secured. 
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3.3.2 BReleaCa: a fluorescent protein that releases BR upon Ca2+ binding 
      A hypothetical kinetic model for the association/dissociation of BR and Ca2+ 
with BReleaCa is shown in Figure 3.4. I first monitored the absorption spectrum during 
the transition from BR-BReleaCa to Ca2+-BReleaCa (Figure 3.3B). The time course was 
very similar to that observed for fluorescence (Figure 3.3A, CaCl2 200 µM). Moreover, 
a clear isosbestic point at 460 nm was noted (Figure 3.3B), which suggests equilibrium 
between the 448- and 494- nm absorbing species (BR-BReleaCa and Ca-BReleaCa, 
respectively). Taken together, it was assumed that the fraction of Ca2+-BR-BReleaCa 
(Figure 3.4, bottom), which may have a distinct spectroscopic property, is negligible. 
I also monitored the absorption spectrum during the transition from Ca2+-BReleaCa to 
BR-BReleaCa (Figure 3.3C). However, no clear isosbestic point was observed, 
suggesting a rather complex mechanism for the reconstitution of BReleaCa (Figure 3.4, 
top) with BR. In fact, I have shown that the reconstitution of apoUnaG with BR consists 
of a rapid generation of a moderately fluorescent species and a slow maturation process 
towards the bright holoUnaG 9. 
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Figure 3.4. Schematic model of the BR- and Ca2+-binding of BReleaCa. BReleaCa 
(top) is the apo-protein generated by bacteria and depleted of Ca2+ ion. It is ready for 
reconstitution with BR to become BR-BReleaCa (right), which emits bright green 
fluorescence. BR-BReleaCa is converted by Ca2+ ion to non-fluorescent Ca2+-BReleaCa 
(left) via Ca2+-BR-BReleaCa (bottom), which may show a very short lifetime and yet 
uncharacterized fluorescence. N, amino terminus. C, carboxyl terminus. Reprinted with 
permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and Atsushi Miyawaki, 
A dual-ligand-modulable fluorescent protein based on UnaG and calmodulin, 
Biochemical and Biophysical Research Communications, 496, 872-879 (2018) 8, 
Elsevier, copyright 2018. Consent from all authors has been secured. 
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3.3.3 The dissociation constant of BReleaaca and BR 
FI measurement makes it possible to examine the equilibrium state of BReleaCa. 
I determined the dissociation constants for BR binding in the presence (Kd (Ca2+(+))) and 
absence (Kd (Ca2+(-))) of Ca2+ by monitoring FI in BR titration experiments. Equation 3.1 
was used to fit the date points (see the derivation of the equation 3.1): 
Pc
Pt
=
Kd +Bt +Pt( )− Kd +Bt +Pt( )
2
− 4 ⋅Bt ⋅Pt
2 ⋅Pt  
where Kd is the dissociation constant, Bt is the total BR concentration, Pt is the total 
protein concentration, and Pc is the concentration of ligand bound protein. Kd (Ca2+(-)) and 
Kd (Ca2+(+)) were determined to be 9.70 nM (Figure 3.5, blue) and 9.65 µM (Figure 3.5, 
red), respectively. The latter curve suggests the existence of a fluorescent species at high 
Ca2+-concentrations: Ca2+-BR-BReleaCa (Figure 3.4). It was therefore concluded that 
the affinity of BReleaCa for BR (Kd (Ca2+(-)) = 9.70 nM) was approximately 100-fold 
weaker than that of UnaG (98 pM) but approximately 1,000-fold stronger than that of 
Ca2+-BReleaCa (Kd (Ca2+(+)) = 9.65 µM). 
･･･Equation (3.1)
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Figure 3.5. One thousand-fold difference in affinity of BReleaCa for BR in the 
presence and absence of Ca2+. Titrations of BReleaCa with BR in the presence (red) 
and absence (blue) of Ca2+. The fraction of BR-BReleaCa (conjugated protein, Pc) to 
whole BReleaCa (total protein, Pt) was plotted. Reprinted with a modification and with 
permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and Atsushi Miyawaki, 
A dual-ligand-modulable fluorescent protein based on UnaG and calmodulin, 
Biochemical and Biophysical Research Communications, 496, 872-879 (2018) 8, 
Elsevier, copyright 2018. Consent from all authors has been secured. 
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The derivation of the Equation (3.1) 
     The chemical equation for the concentrations of BR and BReleaCa in equilibrium 
state can be described as; 
BR[ ]+ BReleaCa[ ]↔ BR−BReleaCa[ ]⇔Kd =
BR[ ] BReleaCa[ ]
BR−BReleaCa[ ]
 
     Now, I define total concentration of BR (Bt), BReleaCa (Pt), and the 
concentration of conjugated protein (Pc) as; 
Bt = BR[ ]+ BR−BReleaCa[ ]
Pt = BReleaCa[ ]+ BR−BReleaCa[ ]
Pc = BR−BReleaCa[ ]
 
Therefore, I obtain, 
Pc =
Kd +Bt +Pt( )− Kd +Bt +Pt( )
2
− 4 ⋅Bt ⋅Pt
2  
     Herein, I define the parameter A, which is the value of FI that BR assumes 
binding to all BReleaCa. The relationship between brightness and concentration of 
protein is described as; 
FI
A =
Pc
Pt
 
where FI indicates the experimental FI for titration. Finally, I can estimate the value of 
Kd by analyzing the Fi value with the function using Kd and A as parameters. The 
equation is described as; 
FI = Kd +Bt +Pt( )− Kd +Bt +Pt( )
2
− 4 ⋅Bt ⋅Pt
2 ⋅Pt
⋅A  
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3.3.4 The association and dissociation rate constant of BReleaCa and BR 
     Next, I investigated the effects of Ca2+-binding on the association/dissociation 
kinetics of BR to BReleaCa. I first determined the association rate (kon) of BR on 
BReleaCa. I performed stopped-flow analysis by mixing 1 µM BReleaCa and 1 µM BR 
in the absence of free Ca2+ ion, and focused on the rapid phase of the FI increase to 
determine the kon (Ca2+(-)) value to be 8.04 × 105 M−1s−1 (Figure 3.6A). I did the same 
measurement in the presence of Ca2+ ion, and determined the kon (Ca2+(+)) value to be 1.99 
× 103 M−1s−1 (Figure 3.6B). 
     I then analyzed the kinetics of dissociation of BR from BR-BReleaCa in both 
Ca2+(-) and Ca2+(+) pathways using UnaG(N57A). As this mutant of UnaG binds to BR 
with the same affinity as the wild-type but is a nearly non-fluorescent, it can be used as 
a quick scavenger of BR 9. Under a Ca2+-depleted condition, I monitored FI during the 
conversion from BR-BReleaCa to BReleaCa (Figure 3.4) after the addition of an excess 
amount of UnaG(N57A). The FI of a solution containing 10 nM BR-BReleaCa decayed 
exponentially after the addition of N57A (~500 nM) (Figure 3.6C), and the dissociation 
rate constant (koff (Ca2+(-))) was determined to be 1.09 × 10-2 s−1. Because of an extremely 
low abundance of the Ca2+-BR-BReleaCa species, on the other hand, the BR 
dissociation process under a Ca2+-saturated condition (Figure 3.4) is hard to analyze. So, 
I started FI measurement from the highly fluorescent species, BR-BReleaCa. After the 
simultaneous addition of CaCl2 with UnaG(N57A), I should be able to monitor the FI 
during the conversion toward BReleaCa via Ca2+-BR-BReleaCa. Based on the fact that 
the association between Ca2+ and CaM is extremely fast (~108 M−1s−1) 15, the FI decay 
was analyzed to determine an apparent value of the dissociation rate constant k’off (Ca2+(+)) 
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to be 2.09 × 10-2 s−1 (Figure 3.6D). These measurements regarding BR binding are 
summarized in Table 3.1. 
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Figure 3.6. Kinetics of BR binding of BReleaCa. (A, B) The time-courses of the 
intensity of fluorescence after the addition of BR (1 µM) to BReleaCa (1 µM) in the 
Ca2+-free (A, blue curve) and Ca2+-saturated (B, red curve) states. (A, B, insets) The 
time-courses in the very early phase (green circles) with the best-fitting lines are shown. 
The right axis of ordinate shows calculated concentrations of BR-BReleaCa (see the 
materials and methods section). (C, D) The time-courses of the intensity of fluorescence 
from BR-BReleaCa (~10 nM) after the addition of 50-fold excess (500 nM) of 
apoN57A in the absence (C, blue) and presence (D, red) of Ca2+ ion. Best-fitting curves 
are drawn in black. Reprinted with a modification and with permission from Yoh 
Shitashima, Togo Shimozawa, Toru Asahi, and Atsushi Miyawaki, A 
dual-ligand-modulable fluorescent protein based on UnaG and calmodulin, Biochemical 
and Biophysical Research Communications, 496, 872-879 (2018) 8, Elsevier, copyright 
2018. Consent from all authors has been secured. 
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Table 3.1 Dissociation constant and kinetic rate constants 
Sample Kd (M) kon (M−1 s−1) koff (s−1) 
UnaG WT8, 13     9.80 × 10-11 7.05 × 106 2.17 × 10-4 
BReleaCa (Ca2+(−))     9.70 × 10-9 8.04 × 105 1.09 × 10-2 
BReleaCa (Ca2+(+))     9.65 × 10-6 1.99 × 103 2.09 × 10-2 
Reprinted with permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and 
Atsushi Miyawaki, A dual-ligand-modulable fluorescent protein based on UnaG and 
calmodulin, Biochemical and Biophysical Research Communications, 496, 872-879 
(2018) 8, Elsevier, copyright 2018. Consent from all authors has been secured. 
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3.3.5 Performance of BReleaCa expressed in cultured mammalian cells 
I performed a Ca2+ titration experiment in the presence of an excess amount of 
BR, and determined the Kd of BR-BReleaCa for Ca2+ binding to be 0.82 µM (Figure 
3.7) by using equation 3.2 (see the derivation of the equation 3.2). 
 
 
Kd of BR-BReleaCa for Ca2+ binding is much higher than the resting level of 
intracellular free Ca2+ concentration ([Ca2+]i) of mammalian cell types. I fused 
BReleaCa to mCherry and transfected the resultant chimeric protein 
(BReleaCa-mCherry) into cultured HeLaS3 cells. I substituted Hank’s balanced salt 
solution without calcium (HBSS(-)) and with 100 µM EGTA for the growth medium. I 
also added 100 nM BR to the HBSS(-). I found that transfected cells emitted green as 
well as red fluorescence, suggesting that BReleaCa folded well enough for BR 
incorporation, and that considering the Kd (Ca2+(-)) value for BR binding (9.70 nM) and 
high cell permeability of BR, the folded molecules existed exclusively as 
BR-BReleaCa. 
I increased [Ca2+]i by addition of 1 µM ionomycin together with 1 mM CaCl2 
(Figure 3.8A, top, time = 0) and found a decrease in the green fluorescence. However, 
the addition of 2 mM EGTA-Na (t = 10 min.) restored the green fluorescence to some 
extent (Figure 3.8A, top). During the time period, the red fluorescence was quite stable 
(Figure 3.8A, middle), and I plotted the ratio of green fluorescence intensity to the red 
FInor =
− KdCa2+ +Cat
2+ −Pt( )+ KdCa2+ +Cat2+ −Pt( )
2
+ 4 ⋅KdCa2+ ⋅Pt
2 ⋅Pt
+α ⋅
KdCa2+ +Cat
2+ +Pt( )− KdCa2+ +Cat2+ +Pt( )
2
− 4 ⋅Cat2+ ⋅Pt
2 ⋅Pt
･･･Equation (3.2) 
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one (Figure 3.8B), which demonstrates that BReleaCa functions as the dual-ligand 
fluorescent protein in mammalian cell types. 
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Figure 3.7. Titration of BR-BReleaCa with calcium using Calcium Calibration 
Buffer Kit #1. Each 1 µM BReleaCa solution containing various concentrations of free 
Ca2+ ions (from 0.064 to 39 µM) was incubated at 20oC until measurement. Each 
sample was measured at 5 min from the addition of excess BR (200 µM). Reprinted 
with permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and Atsushi 
Miyawaki, A dual-ligand-modulable fluorescent protein based on UnaG and calmodulin, 
Biochemical and Biophysical Research Communications, 496, 872-879 (2018) 8, 
Elsevier, copyright 2018. Consent from all authors has been secured. 
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The derivation of the Equation (3.2) 
     The chemical equation for the concentrations of Ca2+ and BR-BReleaCa in 
equilibrium state can be described as; 
  In this situation, I should describe both the concentration of BR-BReleaCa and 
Ca2+-BR-BReleaCa using Pt and Ca2+t (total Ca2+ concentration) because both 
BR-BReleaCa and Ca2+-BR-BReleaCa exhibit fluorescent properties. The concentration 
of BR-BReleaCa and Ca2+-BR-BReleaCa can be described as; 
 
 
     The brightness of BR-BReleaCa and Ca2+-BR-BReleaCa were expressed as 1 and 
a, respectively, the normalized FI is represented by 
 
        
  
Ca2+⎡⎣ ⎤⎦+ BR−BReleaCa[ ]↔ Ca2+ −BR−BReleaCa⎡⎣ ⎤⎦⇔KdCa2+ =
Ca2+⎡⎣ ⎤⎦ BR−BReleaCa[ ]
Ca2+ −BR−BReleaCa⎡⎣ ⎤⎦
BR−BRe leaCa[ ] =
− KdCa2+ +Cat
2+ −Pt( )+ KdCa2+ +Cat2+ −Pt( )
2
+ 4 ⋅KdCa2+ ⋅Pt
2
Ca2+ −BR−BRe leaCa⎡⎣ ⎤⎦=
KdCa2+ +Cat
2+ +Pt( )− KdCa2+ +Cat2+ +Pt( )
2
− 4 ⋅Cat2+ ⋅Pt
2
FInor =
− KdCa2+ +Cat
2+ −Pt( )+ KdCa2+ +Cat2+ −Pt( )
2
+ 4 ⋅KdCa2+ ⋅Pt
2 ⋅Pt
+α ⋅
KdCa2+ +Cat
2+ +Pt( )− KdCa2+ +Cat2+ +Pt( )
2
− 4 ⋅Cat2+ ⋅Pt
2 ⋅Pt
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Figure 3.8. Ca2+-regulated fluorescence of BReleaCa in HeLa S3 cells. HeLa cells 
were transfected with the cDNA of BReleaCa-mCherry fusion, and time-lapse imaged. 
(A) top, Decrease in the BReleaCa green fluorescence after the addition of 1 mM CaCl2 
and 1 µM ionomycin at 0 min, and its recovery after the addition of 2 mM EGTA-Na at 
10 min. middle, The mCherry red fluorescence was nearly constant. bottom, Ratio 
images of green to red. Scale bar, 100 µm. (B) Time courses of the ratio of the green 
fluorescence to the mCherry red fluorescence from three independent experiments. 
Typical images selected from Exp. 1 are presented in (A). Reprinted with permission 
from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and Atsushi Miyawaki, A 
dual-ligand-modulable fluorescent protein based on UnaG and calmodulin, Biochemical 
and Biophysical Research Communications, 496, 872-879 (2018) 8, Elsevier, copyright 
2018. Consent from all authors has been secured. 
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3.4 Discussion 
3.4.1 Challenging of other type of BR releasing protein 
     To offer Ca2+ sensitivity to a BR-inducible fluorescent protein, in this study, I 
constructed 6 UnaG/CaM hybrid proteins. After affinity tag purification of bacterially 
expressed proteins and reconstitution with BR, I measured absorption spectra of their 
Ca2+ -free form (Figure 3.9). Among the 6 hybrid proteins, only #3 folded well enough 
to bind BR and exhibited light absorption peaking sharply at 494 nm. Moreover, the 
holoUnaG-derived absorption peak at 494 nm was reversibly sensitive to Ca2+ ion. In 
contrast, the 494- nm absorption peak was never detected with #1, and although the 
peak was very faintly observed for #2, #4, #5 and #6, none of them responded to Ca2+ 
ion. With preparations of #1, #2, #4, #5, and #6, furthermore, I noticed that the 
transmittance was substantially reduced irrespective of the wavelength, and thus 
suspected their aggregation due to misfolding. Taken together, their failure in folding 
could be simply explained by UnaG’s intolerance of the insertions.  
     A number of genetically encoded calcium indicators have been developed by 
introducing a cleft on the wall of the b-can fold of Aequorea GFP variants. On the one 
hand, most of the SFPBI, including G-CaMP, GCaMP, and pericam, are chimeric 
constructs that fuse circularly permuted variants of Aequorea GFP, such as cp145GFP 
and cp145YFP, to CaM and the CaM-binding peptide of myosin light-chain kinase 
(M13) 5, 16, 17. So far, however, I have not been able to fuse cp85UnaG to CaM and M13 
for our purpose (#5 and #6). More trial and error will be required to optimize protein 
integrity (folding efficiency). On the other hand, Camgaroo was successfully 
constructed by inserting only CaM between positions 145 and 146 of YFP 6. Likewise, 
successful insertion between positions 84 and 85 of UnaG was achieved with CaM (#3) 
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but not CaM-M13 (#4) in our current study.  
     #3 appeared to ensure correct folding of both of the 2 protein modules: UnaG and 
CaM. In the present study, I investigated the interplay between the BR-induced 
development of green fluorescence and Ca2+ -induced conformational change on the 
protein. As #3 binds BR to become fluorescent and releases BR in response to Ca2+ ion, 
I named the protein “BReleaCa”. The Ca2+ -free form “BR-BReleaCa” (Figure 3.4) 
emitted very bright green fluorescence. I compared absorption, excitation and 
fluorescence spectra between UnaG and BReleaCa (Figure 3.10), and I quantified its 
molar extinction coefficient (62,400 M-1cm-1) and fluorescence quantum yield (0.40), 
which were comparable to those of the wild-type UnaG (77,300 M-1cm-1 and 0.51, 
respectively) (Table 3.2). 
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Figure 3.9. Absorption spectra of UnaG/CaM hybrid proteins. In all experiments, 1 
µM BR and 100 µM EGTA-Na were added in each protein solution (1 µM) before 
measurement. Black line; Absorption spectra of 1 µM BR. Absorption spectra of #1 (A), 
#2 (B), #3 (BReleaCa, C), #4 (D), #5 (E), and #6 (F) chimeric protein before (blue line) 
and after (green line) addition of 200 µM CaCl2. Reprinted with a modification and with 
permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and Atsushi Miyawaki, 
A dual-ligand-modulable fluorescent protein based on UnaG and calmodulin,
Biochemical and Biophysical Research Communications, 496, 872-879 (2018) 8, 
Elsevier, copyright 2018. Consent from all authors has been secured. 
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Figure 3.10. Spectroscopic studies for comparing UnaG and BReleaCa. (A) 
Absorption spectra of UnaG (dotted line) and BReleaCa (solid line) in the absence of 
Ca2+ (Ca2+(-)). 1 µM BR and 100 µM EGTA-Na were added in UnaG and BReleaCa (1 
µM each) protein solution. (B) Excitation and fluorescence spectra of UnaG (dotted 
line) and BReleaCa (black line) (1 µM each) with 1 µM BR and 100 µM EGTA-Na 
(Ca2+(-)). Reprinted with permission from Yoh Shitashima, Togo Shimozawa, Toru 
Asahi, and Atsushi Miyawaki, A dual-ligand-modulable fluorescent protein based on 
UnaG and calmodulin, Biochemical and Biophysical Research Communications, 496, 
872-879 (2018) 8, Elsevier, copyright 2018. Consent from all authors has been secured. 
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Table 3.2 Fluorescence characteristics od UnaG and BR-BReleaCa 
Reprinted with permission from Yoh Shitashima, Togo Shimozawa, Toru Asahi, and 
Atsushi Miyawaki, A dual-ligand-modulable fluorescent protein based on UnaG and 
calmodulin, Biochemical and Biophysical Research Communications, 496, 872-879 
(2018) 8, Elsevier, copyright 2018. Consent from all authors has been secured.  
 ex/em 
maxima (nm) 
Molar extinction 
coefficient (M-1cm-1) 
Fluorescence 
quantum yield 
UnaG13 498/527 77,300 (498 nm) 0.51 
BReleaCa (Ca2+(-)) 498/527 62,400 (498 nm) 0.40 
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     Additionally, I attempted to insert CaM into cpUnaG (cpBReleaCa). CaM was 
inserted between the original N and C terminus, and N terminus of cpBReleaCa starts at 
the amino acid residue 85 position and the C terminus ends at residue 84. Although 
cpBReleaCa exhibited some responses to Ca2+, this BR releasing protein could not bind 
completely 1 µM BR in the Ca2+-free state, indicating that the Kd value between 
cpBReleaCa and BR under a Ca2+-depleted condition would larger than that between 
BReleaCa and BR. Moreover, I attempted to change the insertion position of CaM, in 
place between residues 24 and 25, or in place between residues 57 and 58. The position 
in the former is inter two a-helix and the position in the latter is near the key amino acid 
Arg57 9, 13; needless to say, both position are very close to BR binding pocket in UnaG. 
Although both BR releasing protein exhibited some responses to Ca2+, they could not 
release completely 1 µM BR in the Ca2+-saturated state, indicating that the Kd value 
between these proteins and BR in the Ca2+-saturated state would larger than that 
between BReleaCa and BR. In both cases, the differences of BR binding affinities for 
these proteins between the absence and presence of excess Ca2+ are expected to be 
smaller than that for original BReleaCa.  
     From these facts, I believe that original BReleaCa is currently the best designed 
BR releasing protein based on UnaG. 
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3.4.2 Consideration of portal region of UnaG from BReleaCa 
     Based on the view that the rate constants of association and dissociation of a 
ligand are largely related to the portal region and binding cavity, respectively, I discuss 
observed alterations of the kinetics of BR binding in two steps: insertion and 
conformational change of CaM. First, in the absence of Ca2+ ion, the insertion of 
apoCaM at 84/85 resulted in a ~100-fold decrease in the affinity of UnaG for BR (Kd, 
9.80 × 10-11 M vs. 9.70 × 10-9 M). Because residues 84 and 85 are localized close to the 
propionate group protruding from the C ring of BR, the insertion should increase the 
rate constant of BR dissociation; the koff (Ca2+(-)) value of BReleaCa (1.09 × 10-2 s-1) was 
approximately 100 times greater than the koff of UnaG (2.17 × 10-4 s-1). Second, the 
conversion from apoCaM to holoCaM upon binding to Ca2+ ion might cause some 
conformational change within the UnaG moiety, probably affecting the entry region for 
BR to a greater extent than the binding cavity. According to this speculation, kon(Ca2+(+)) 
(1.99 × 103 M-1s-1) was approximately 400 times lower than kon(Ca2+(-)) (8.04 × 105 M-1s-1), 
while koff (Ca2+(+)) (2.09 × 10-2 s-1) was just a double of the koff (Ca2+(-)) value. 
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3.4.3 The possibility of utilizing BReleaCa 
     I determined the fluorescence quantum efficiency (QE) of BReleaCa to be 0.4, 
which is comparable to that of UnaG (0.51). It is possible that BReleaCa can be used as 
a transient binder of the fluorogenic ligand, bilirubin, for super-resolution imaging. The 
molar ratio of the bright bound state to non-fluorescent states can be controlled by Ca2+ 
ions according to object density. Further studies, including single molecule analysis of 
BReleaCa at different Ca2+ concentrations, will be necessary. 
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3.5 Conclusion 
     In conclusion, I have succeeded in rationally designing a Ca2+-dependent bilirubin 
releasing protein, BReleaCa, based on the insertion of conformationally sensitive 
receptors into a ligand-binding protein. The resultant protein bound to BR with a Kd 
value of 9.70 nM in the Ca2+-free state, and with a Kd value of 9.65 µM in the 
Ca2+-saturated state. In kinetics study, the difference in BR binding affinities for 
BReleaCa in the absence and presence of excess Ca2+ was dominated by the difference 
of kon rather than that difference of koff. Moreover, The BR releasing ability of the novel 
created protein also functioned in cells; therefore, BReleaCa may be promising as a 
Ca2+-inducible regulator of BR concentrations in biological tissues.  
     The strategy in this study may be widely applicable as a method of modulating 
protein-ligand affinity by using distinct molecules. Additionally, insertions of various 
foreign proteins in the site between residues 84 and 85 provide UnaG with expansions 
of dynamic range for BR sensing in cells. Furthermore, BReleaCa may contribute to 
super-resolution imaging field in the future. This study opens wider possibilities for 
UnaG application. 
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Chapter 4 
Summary and Future Prospect 
     In this thesis, the characteristic of UnaG and its novel application were studied. 
The former study is summarized in Chapter 2 and the latter is summarized in Chapter 3.  
     In Chapter 2, the most remarkable achievement is discovering that holoUnaG is 
the mixture of two distinctive fluorescent molecules by using fluorescence intensity 
distribution analysis (FIDA). The trigger of this discovery was careful observation of 
FI-time course for measuring the association/dissociation rates of UnaG and BR. The 
time-dependent green fluorescence of apoUnaG upon addition of BR was investigated, 
and I finally identified that the holoUnaG solution immediately showed strong 
brightness (rapid phase), and subsequently the fluorescence intensity gradually 
increased to a plateau (slow phase). From both the fitting analysis of FI time-course in 
show phase under various UnaG concentrations and the result of analytical 
ultracentrifugation analysis, the slow FI increase was associated with an intra-molecular 
reaction within the already formed holoUnaG molecule. To clarify this hypothesis, I 
subjected holoUnaG to FIDA. Finally, I demonstrated that apoUnaG was converted to 
holoUnaG1 immediately, and subsequently holoUnaG1 was gradually converted to 
holoUnaG2, which acquired 3.9 times higher brightness than holoUnaG1. Both 
holoUnaG1 and holoUnaG2 reached equilibrium state with an average 
holoUnaG1/holoUnaG2 ratio of 60:40. From these results, I suggested the novel schema 
for the formation of the UnaG and BR complex system, and determined the various rate 
constants including the association/dissociation rates of UnaG and BR. The finding in 
Chapter 2 provided useful information for the application of UnaG. And, the idea of 
utilizing FIDA instead of single-molecular imaging is my own original method. This 
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method would be apply for the analysis of other fluorescence protein, so I think my 
study would give high impact in this field. 
     In Chapter 3, I offered the Ca2+ sensitivity to UnaG via a genetic insertion of a 
calmodulin (CaM) domain. The originality of this study is the idea of regulating the 
affinity of ligand binding by using other molecule. The resultant protein decreased its 
affinity for BR by ~1,000-fold by increasing Ca2+ ion concentration. Moreover, I 
calculate the quantum yield of BReleaCa and it was estimated to be 0.4. This value is 
relatively high for fluorescent protein quantum yield, indicating that BReleaCa is 
suitable element for single-molecular imaging. I believe that my findings will open the 
possibility for UnaG application of UnaG as an element for super-resolution imaging in 
the future. The strategy in this study may be widely applicable as a method for 
generating intentional changes to protein-ligand affinity. Thus, I strongly assert that this 
study represents a significant contribution to researchers in the protein-engineering 
field. 
     For future prospect, there are several possibilities in my study. For example, 
nobody knows which dipyrrinone moieties exhibit fluorescence properties. Possibly, 
one-sided dipyrrinone moieties may exhibit fluorescence properties in holoUnaG1, and 
both dipyrrinone moieties may exhibit fluorescence properties in holoUnaG2. I would 
like to separate holoUnaG1 from holoUnaG2 completely in the future. For this challenge, 
I have to determine the difference between holoUnaG1 and holoUnaG2 at first. I would 
like to determine the key residue for playing a role of transition between holoUnaG1 and 
holoUnaG2, and finally achieve to generate the super-UnaG whose QE is ~90%. In 
BReleaCa, I would like to utilize BReleaCa as a functional element in vitro, like 
DNA-origami. For example, BReleaCa has a potential to be a useful labelled protein for 
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point accumulation for imaging in nanoscale topography (PAINT) as described in 
Chapter 3. If we utilize BReleaCa for PAINT, fluorescent densities would be easily 
controlled by Ca2+ ion. The study in this thesis will open the possibility of UnaG as a 
useful protein, and lead to create various novel functional protein based on fluorescent 
protein (Figure 4.1). 
Figure 4.1. Prospects for future research of UnaG.
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